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1. INTRODUCTION TO THE NATIONAL HEALTH AND  
NUTRITION EXAMINATION SURVEY 
This chapter provides a general description of the health examination surveys conducted by 
the National Center for Health Statistics (NCHS) and the ongoing National Health and Nutrition 
Examination Survey (NHANES). It also provides an overview of the tasks the interviewers are expected 
to perform during the survey. 
1.1 History of the National Health and Nutrition Examination Programs 
The National Health Survey Act, passed in 1956, provided the legislative authorization for a 
continuing survey to provide current statistical data on the amount, distribution, and effects of illness and 
disability in the United States. To fulfill the purposes of this act, it was recognized that a data collection 
effort needed to be implemented that would involve at least three sources: (1) the people themselves by 
direct interview; (2) clinical tests, measurements, and physical examinations on sample persons; and 
(3) places where persons received medical care such as hospitals, clinics, and doctors’ offices.  
The NHANES surveys were created to fulfill this information need. They are unique in that 
interview and physical examination data are obtained from national samples of the U.S. population. The 
examination component is conducted in mobile examination centers (MECs) that travel to fifteen survey 
locations per year. NHANES data have been the cornerstone for numerous national health and nutrition 
policy and surveillance activities. 
To comply with the 1956 act, between 1960 and 2004, the National Center for Health 
Statistics (NCHS), a branch of the Centers for Disease Control and Prevention (CDC), in the U.S. 
Department of Health and Human Services, conducted seven separate examination surveys to collect 
interview and physical examination data. In 1999, NHANES became a continuous survey with year round 
data collection. 
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The first three of these national health examination surveys were conducted in the 1960s: 
1. 1960-62—National Health Examination Survey I (NHES I); 
2. 1963-65—National Health Examination Survey II (NHES II); and 
3. 1966-70—National Health Examination Survey III (NHES III); 
NHES I focused on selected chronic disease of adults aged 18-79. NHES II and NHES III 
focused on the growth and development of children. The NHES II sample included children aged 6-11, 
while NHES III focused on youths aged 12-17. All three surveys had an approximate sample size of 
7,500.  
Beginning in 1970 a new emphasis was introduced. The study of nutrition and its 
relationship to health status had become increasingly important as researchers began to discover links 
between dietary habits and disease. In response to this concern, under a directive from the Secretary of the 
Department of Health, Education and Welfare, the National Nutrition Surveillance System was instituted 
by NCHS. The purpose of this system was to measure the nutritional status of the U.S. population and 
changes over time. A special task force recommended that a continuing surveillance system include 
clinical observation and professional assessment as well as the recording of dietary intake patterns. Thus, 
the National Nutrition Surveillance System was combined with the National Health Examination Survey 
to form the National Health and Nutrition Examination Survey (NHANES). Five surveys of this type 
have been conducted since 1970: 
4. 1971-75—National Health and Nutrition Examination Survey I (NHANES I); 
5. 1976-80—National Health and Nutrition Examination Survey II (NHANES II); 
6. 1982-84—Hispanic Health and Nutrition Examination Survey (HHANES); and 
7. 1988-94—National Health and Nutrition Examination Survey (NHANES III). 
NHANES I, the first cycle of the NHANES studies, was conducted between 1971 and 1975. 
This survey was based on a national sample of about 28,000 persons aged 1-74. Extensive data on health 
and nutrition were collected by interview, physical examination, and a battery of clinical measurements 
and tests from all members of the sample.  
NHANES II began in 1976 with the goal of interviewing and examining 28,000 persons 
aged 6 months to 74 years. This survey was completed in 1980. To establish a baseline for assessing 
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changes over time, data collection for NHANES II was made comparable to NHANES I. This means that 
in both surveys many of the same measurements were taken, the same way, on the same age segment of 
the U.S. population.  
While the NHANES I and NHANES II studies provided extensive information about the 
health and nutritional status of the general U.S. population, comparable data were not available for many 
of the ethnic groups within the United States. HHANES, fielded from 1982 to 1984, aimed at producing 
estimates of health and nutritional status for the three largest Hispanic subgroups in the United States—
Mexican Americans, Cuban Americans and Puerto Ricans—that were comparable to the estimates 
available for the general population. HHANES was similar in design to the previous HANES studies, 
interviewing and examining about 16,000 people in various regions across the country where there are 
large Hispanic populations.  
NHANES III, conducted between 1988 and 1994, included approximately 40,000 persons 
selected from households in 81 counties across the United States. As previously mentioned, minority 
groups can have very different health status and characteristics, and thus black Americans and Mexican 
Americans were selected in NHANES III in large proportions. Each of these groups comprised 30 percent 
of the sample. It was the first survey to include infants as young as 2 months of age and to include adults 
with no upper age limit. For the first time a home examination was developed for those persons who were 
unable or unwilling to come into the exam center but would agree to an abbreviated examination in their 
homes. To obtain reliable estimates, children (1-5 years) and older persons (60+ years) were sampled at a 
higher rate. NHANES III also placed an additional emphasis on the effects of the environment upon 
health. Data were gathered to measure the levels of pesticide exposure, the presence of certain trace 
elements in the blood, and the amounts of carbon monoxide present in the blood. 
In 1999, NHANES resumed data collection and became a continuous survey. Every 2 years, 
and any combination of consecutive years of data collection, constitutes a nationally representative 
sample of the U.S. population. This design allows for statistical estimates for groups and specific race-
ethnicity groups as well as flexibility in the content of the questionnaires and exam components. New 
technologic innovations in computer-assisted interviewing and data processing resulted in rapid and 
accurate data collection, data processing, and publication of results.  
The number of people examined in a 12-month period was about the same as in previous 
NHANES—about 5,000 a year from 15 different locations across the Nation. The data from the 
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NHANES have been used by government agencies, state and community organizations, private 
researchers, consumer groups, companies, and health care providers.  
In addition to NHANES I, NHANES II, Hispanic HANES, and NHANES III, several other 
HANES projects have been underway since 1982. These projects have been a part of the HANES 
Epidemiologic Follow-up Survey, a multiphase project that has been conducting follow-up interviews 
with the NHANES I survey population in order to provide a longitudinal picture of the health of the U.S. 
population.  
1.2 Overview of NHANES 
NHANES is designed to collect information about the health and diet of people in the United 
States. These data are used to fulfill specific goals. The overall goals of NHANES are to: 
 Estimate the number and percent of persons in the U.S. population and designated 
subgroups with selected diseases and risk factors; 
 Monitor trends in the prevalence, awareness, treatment, and control of selected 
diseases; 
 Monitor trends in risk behaviors and environmental exposures; 
 Analyze risk factors for selected diseases; 
 Study the relationship between diet, nutrition, and health; 
 Explore emerging public health issues and new technologies; and 
 Establish a national probability sample of genetic material for future genetic testing. 
Each year, a nationally representative sample of the civilian, non-institutionalized U.S. 
population, all ages, is interviewed and examined. NHANES data are released in 2-year cycles. One-year 
estimates may be produced if there is a compelling public health need and if one year of data can provide 
a reliable estimate. Data from 2-year cycle NHANES 1999–2008 are posted on the NHANES website. 
The URL is http://www.cdc.gov/nchs/nhanes.htm. A major advantage of continuous NHANES data 
collection is the ability to address emerging public health issues and provide objective data on more 
health conditions and issues. 
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Westat has been contracted to conduct the study through 2014. Each year nearly 7,000 
individuals of all ages in households across the United States are randomly selected to participate. The 
study respondents include whites/others as well as an oversample of blacks, Hispanics, and starting in 
2011, Asians. The study design also includes a representative sample of these groups by age, sex, and 
income level. Older persons will also be oversampled. 
Selected persons are invited to take part in the survey by being interviewed in their homes. 
Household interview data is collected via computer-assisted personal interviewing (CAPI) and includes 
demographic, socioeconomic, dietary, and health-related questions. Upon completion of the interview, 
sample persons are asked to participate in a physical examination. The examination will be conducted in a 
specially equipped and designed Mobile Examination Center (MEC), consisting of four trailers. The MEC 
houses all of the state-of-the-art equipment for the physical exam and the tests conducted. The trailers are 
divided into rooms to ensure the privacy of each study participant during the examination and interview. 
This examination includes a physical examination conducted by a physician and laboratory tests, X-rays, 
and other health measurements and interviews conducted by highly trained medical personnel. The 
household interviews and MEC exams combined will collect data in the following important health 
related areas: 
 Cardiovascular and respiratory disease; 
 Diabetes mellitus; 
 Oral health; 
 Hearing; 
 Infectious diseases and immunization status; 
 Obesity, growth, and development; 
 Dietary intake and behavior; 
 Nutritional status; 
 Physical activity; 
 Mental health; 
 Environmental exposures; and 
 Other health-related topics. 
1-6 
1.3 Field Organization for NHANES 
There are two levels of field organization for this study—the home office staff and the field 
staff.  
 Home Office Staff from Westat—Project staff from Westat are responsible for 
overseeing the field work.  
 Field Staff—The field staff consists of three groups of employees: The stand office 
staff, the interviewers, and the MEC staff. 
- Stand Office Staff—For the main study, there are three office staff teams. Each 
team will work at an office opened at a specific site (i.e., stand). Each stand 
office will be headed by a study manager (SM) and will include a field manager 
(FM), an office manager (OM), an assistant office manager (AOM), and a data 
equipment specialist (DES). 
- The study manager (SM) is responsible for the overall management of 
operations at a stand. S/he will also have primary responsibility for 
supervision of the household interviewers (health representatives). 
- The field manager’s primary responsibility is to assist the SM and 
supervise the activities of the AOM. He or she will deal with 
administrative issues and ISIS and CAPI problems. 
- The office manager is responsible for the stand office operations and is 
the main conduit for the flow of work and information between the MEC 
and the household interviewing staff. S/he supervises one or more local 
office clerks hired to assist with office activities.  
- The assistant office manager is primarily responsible for quality control 
including data entry into the Integrated Survey Information System 
(ISIS), editing data collection materials, and verification of interviewer 
work. 
- The facilities equipment specialist is primarily responsible for the set up 
and maintenance of the field office computer systems and the MEC 
physical plant. S/he reports to the home office advance team staff. 
- Interviewers—This staff is primarily responsible for identifying and enrolling 
the survey participants, conducting the household interviews, and appointing 
the study participants for health examinations. 
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- Several times a week interviewers visit the stand office and report to the 
study manager. During the course of the study interviewers also interact 
with the other field office staff as well as home office staff.  
- MEC Staff—This staff of health professionals conducts the physical 
examinations. The main study includes two exam teams traveling from stand to 
stand. There are 16 individuals on each traveling team: 1 MEC manager, 1 
MEC coordinator, 1 licensed physician, 1 licensed dentist, 3 medical 
technologists, 4 health technicians, 2 MEC interviewers, 2 dietary interviewers, 
and 1 phlebotomist. In addition, local assistants are recruited, trained, and 
employed at each stand to assist the exam staff.  
- TB Readers—These staff are responsible for conducting TB readings with 
survey participants who received the TB antigens during their MEC exam, 
making reminder calls, and entering results into the Field Follow-up 
Management System (FFMS). The TB Readers report to the home office. 
1.4 Overview of TB Reader Tasks 
This section provides an overview of the tasks TB Readers will be expected to perform. 
Each of these tasks is discussed in detail in later sections of this manual. In the overview that follows, 
certain key items are highlighted. The tasks TB Readers perform at a stand include:  
1. Review daily schedule of appointments and note any comments from MEC staff; 
2. Conduct appointment reminder telephone calls; 
3. Contact sample persons (SPs) to reschedule missed appointments or to schedule an 
appointment for SPs who were not scheduled during their MEC exam;  
4. Manage petty cash and provide the TB and transportation incentives to SP when their 
TB reading is completed; 
5. Conduct TB readings in the field office; 
6. Visit SP homes to conduct TB readings for SPs who cannot or refuse to come to the 
field office for their reading; 
7. Use the TB Reading application to record test results; 
8. Use the FFMS to manage appointments, reminder calls, and generating reports; 
9. Work with interpreters as necessary;  
1-8 
10. Report adverse events/findings through the appropriate processes; and 
11. Assist the field office staff with additional office tasks as needed. 
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2. TUBERCULOSIS SKIN TESTING 
2.1 Overview of TB and TB Skin Testing 
The Centers for Disease Control and Prevention (CDC), Division of Tuberculosis (TB) 
Elimination, is responsible for the TB skin-testing component of NHANES. The objective is to determine 
the prevalence of TB infection in the U.S. population. All sample persons (SPs) aged 6 years or older are 
offered testing for infection with the bacterium that causes TB. 
TB is a disease caused by a germ called Mycobacterium tuberculosis that is spread from 
person to person through the air. TB usually affects the lungs, but it can also affect other parts of the 
body, such as the brain, the kidneys, or the spine. When a person with infectious TB coughs or sneezes, 
droplet nuclei containing M. tuberculosis are expelled into the air. If another person inhales air containing 
these droplet nuclei, he or she may become infected. However, not everyone infected with TB bacteria 
becomes sick. As a result, two TB-related conditions exist: latent TB infection and active TB disease. 
Persons with latent TB infection do not feel sick and do not have any symptoms. They are 
infected with M. tuberculosis, but do not have active TB disease. The only sign of TB infection is a 
positive reaction to the tuberculin skin test or TB blood test. Persons with latent TB infection are not 
infectious and cannot spread TB infection to others.  
Overall, about 5–10 percent of infected persons will develop active TB disease at some time 
in their lives. About half of those people who develop active TB will do so within the first 2 years of 
infection. For persons whose immune systems are weak, especially those with HIV infection, the risk of 
developing active TB disease is considerably higher than for persons with normal immune systems. 
People exposed to someone with active untreated infectious TB for prolonged periods are 
most likely to acquire the disease. Casual brief contact is unlikely to result in TB transmission.  
Tuberculin skin tests and blood tests, allow clinicians to look for TB infection in household 
or workplace contacts of people with active disease. Treatment to prevent active TB disease is 
recommended for some persons whose skin test and clinical evaluation indicate TB infection, but who do 
not have TB disease, and who do not have contraindications to the medications.   
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2.2 TB Epidemiology 
In the late 1980s TB reemerged as a serious problem in the United States. The major factors 
contributing to the increase in TB cases included deterioration of the public health infrastructure, the 
higher risk of TB associated with human immunodeficiency virus (HIV) infection, immigration from 
countries where TB is common, and outbreaks of TB in congregate settings (health care facilities, prisons, 
homeless shelters). Appropriate treatment was less available to many people with active disease who 
remained infectious for longer periods. Many others began treatment but were not followed to see if they 
had completed treatment. Few staff were available to test household contacts and prescribe treatment for 
those who were infected. Lack of public health resources resulted in a rise in TB cases. 
A few geographic areas centered in large cities accounted for a large proportion of the rise in 
TB case rates. In most of those areas, including New York City, additional money was devoted to TB 
prevention and control in the early 1990s, and the numbers of cases began to decline in 1993. However, 
some groups remain at higher risk than others. These groups can be divided into two categories, people 
who are more likely to be exposed to TB, and people more likely to develop TB disease once infected. 
People more likely to be exposed to TB include the following: 
 Close contacts of a person with infectious TB; 
 Foreign-born persons from areas of the world where TB is common; 
 Medically underserved populations, low-income populations; 
 Residents and employees of congregate settings whose clients are at increased risk for 
active TB; and 
 Other groups identified locally as having an increased incidence of latent TB 
infection. 
People more likely to develop TB disease once infected include the following: 
 People whose immune systems are compromised (including those with HIV, diabetes 
mellitus, and some cancers); 
 Infants and children; 
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 The elderly; and 
 Populations defined locally as having an increased incidence of active TB. 
Because of inadequate or inconsistent TB treatment, some individuals with active TB 
develop resistance to one or more of the medications used to treat TB. Drug-resistant TB is more difficult 
to treat and requires more medications and longer treatment periods.  
Reporting cases of active TB helps public health personnel understand how well TB 
programs are working, but active disease represents only the tip of the iceberg. The much larger group of 
infected people without active TB is at risk of developing active disease some time in the future. In order 
to reach the national goal of TB elimination in the United States, it is critical to know the proportion of 
the population infected with TB, and test and treat the groups identified as having higher rates of 
infection.  
Survey questions in conjunction with tuberculin skin testing can be utilized to estimate the 
percentage of a population infected with TB. Surveys also look at whether higher proportions of infected 
people are in certain geographic or ethnic groups. Studies estimate the overall number of TB-infected 
people in an area, and the groups most at risk of infection help evaluate the effectiveness of TB 
prevention and control programs and target areas for additional efforts. 
NHANES I conducted in 1971–72 included a tuberculin skin testing component. The results 
allowed CDC to estimate that, at that time, TB infection occurred in 21.5 percent of the U.S. population 
between the ages of 25 and 74. NHANES 1999–2000 collected data and skin test results from 7,386 
participants and determined that 4.2 percent of the civilian, non-institutionalized population, or 
11,213,000 people, had latent TB infection (LTBI) in 1999–2000. NHANES 2011–2012 is the first 
population-based survey of TB infection in the U.S. population since NHANES I and will compare TB 
skin test results and blood test results for the diagnosis of TB infection in a representative sample of the 
U.S. population. It will be the first national study of the prevalence of TB infections in the United States 
based on this more specific blood test approved by the Food and Drug Administration in 2005.  
NHANES 2011–2012 data will provide information on infection to supplement TB reports 
regularly received from TB control programs in health departments across the country, to achieve TB 
elimination in the United States. 
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2.3 Overview of TB Skin Testing 
To detect TB infection, a small drop of filtered tuberculin liquid is injected just under the top 
layer of the skin. The most commonly used TB skin test currently available uses purified protein 
derivative (PPD), a sterile fluid that contains killed purified, standardized mycobacteria components. If 
the person has been infected with TB, the immune system produces a response on the skin in the area of 
the test. This reaction is usually a small hard raised area of skin, which can be felt with the fingertips 48–
72 hours after placing the test. TB skin test readers measure the reaction in millimeters (mm). Different 
reaction sizes, depending on the person being tested and the purpose of the test, are defined as positive, 
indicating that TB infection may have occurred at some time in the person’s life.  
In persons not previously infected with TB, the TB skin test usually produces no reaction, or 
sometimes produces a little redness or some soft swelling. These mild reactions represent irritation and do 
not indicate TB infection. A red area that is not raised or hard is not a measurable reaction. 
Pregnant women, young children, people with immune system deficiencies, people who 
have recently had immunizations, and people who have had a positive TB test result in the past, can have 
a TB skin test. The test is contraindicated for people who have previously had a severe allergic reaction, 
including an anaphylactic reaction (an allergic response involving the whole body) and/or ulceration(s) at 
the test site. A severe allergic reaction is uncommon and usually subsides within a few days. No such 
reactions were recorded during NHANES I or II. Itching, redness, or swelling after a previous TB skin 
test does not disqualify a person for the NHANES TB skin test. 
A positive reaction to the TB skin test indicates TB infection and does not mean the person 
has active TB disease. As noted earlier, only people with active TB disease can transmit TB to others. 
2.4 Limitations of Tuberculosis Skin Testing and Implications 
Tuberculin skin testing is the most commonly used test for TB infection, but it has 
limitations. Some people who are infected with TB and who have other health problems, especially 
diseases affecting the immune system, may have a negative TB skin test result, that is, a false negative 
skin test result. False positive TB skin test results are also possible, and are more common when the 
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proportion of TB infection in a population is low. In some areas of the U.S. with low incidence of TB, 
this could lead to an overestimate of the proportion of people infected with TB. Finally, variability in the 
techniques of the person placing the skin test and reading results is a limitation. 
2.5 TB Skin Test Results 
SPs aged 6 years or older receive a TB skin test. TB skin tests have been used safely in many 
surveys in the United States and elsewhere, and will provide an estimate, as does the newer blood test, of 
the prevalence of TB infection in the United States. SPs whose PPD tuberculin skin test result is above a 
minimum cutoff value (>10 mm) are given a written Report of Findings that states that they may have 
been infected with TB at some time during the past. They are instructed to contact their primary source of 
medical care or the TB control program at the local health department for a clinical evaluation.  
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3. PROTOCOL FOR PLACING SKIN TEST ANTIGENS 
3.1 Overview 
Place or administer purified protein derivative (PPD) antigen on all sample persons (SPs) 
aged 6 years and older if they have completed phlebotomy. There is one safety exclusion question for TB. 
Ask SPs if they have had a previous severe reaction to the tuberculin antigen. Exclude only those who 
report a previous severe allergic reaction involving the whole body and/or ulceration at the site of a 
previous TB skin test from the TB component. There are two inclusion criteria. First, ask the SPs if they 
are available 46-76 hours after the placement to measure skin reactions. Second, examine the SPs to make 
sure that they have a forearm available for placement. Following the examination, each SP receives a 
tuberculin skin test (PPD) preferably in the left forearm if available. After administering the antigen, the 
phlebotomist schedules an appointment for the SP to return to the field office to have the skin reaction 
measured. The phlebotomist provides instructions informing the SP not to scratch or put lotions or 
ointment on the skin test areas. The coordinator gives the SP an appointment reminder card when the SP 
checks out of the MEC. Although TB skin tests can be measured 46-76 hours after placing the antigens, 
make initial appointments for the period 48-52 hours, if possible. This allows the TB reader time to 
contact the SPs if they miss their scheduled appointment. 
3.2 The Phlebotomy Component 
The phlebotomy component consists of blood collection, TB skin testing, and the Oral 
Glucose Tolerance Test (OGTT). Conduct the blood collection first, followed by the TB skin test, and 
then the OGTT. If the blood collection is delayed so that the SP can meet the fasting requirement, send 
the SP back to the coordinator area until the fast is met. Conduct the blood collection and TB skin test 
when the SP returns to phlebotomy after meeting the fasting requirement. 
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3.3 Equipment and Supplies 
The equipment and supplies required to place skin test antigens are listed below: 
 Needle: sterile ½ inch., 27 gauge, short bevel 
 Alcohol wipes 
 2 x 2 gauze pads 
 Latex gloves 
 Puncture-resistant sharps disposal container 
 Permanent marking pen for labeling 
 Small rectangular basket for housing single vial of Tubersol and prefilled syringe 
 Stock multidose antigen vials stored in appropriately labeled box in laboratory 
refrigerator 
 Laboratory refrigerator with automatically monitored temperature system 
 Phlebotomy and TB refrigerators with a thermometer to manually monitor 
temperature recording  
 Adverse Reaction Forms 
 TB ruler with odd markings 
3.3.1 General Principles for Handling and Storing the PPD Antigens 
The principles for appropriate handling of the skin test antigen include controlling 
temperature, light, time in the syringe, and labeling. 
Store skin test antigen in a temperature-monitored refrigerator except when removing the 
antigen to fill the syringe. Do not allow filled syringes to stand for more than 20 minutes before use, and 
discard unused filled syringes after 20 minutes. More than a brief exposure to room temperature or light 
can make the skin test antigen less effective. If syringes are prefilled and the liquid containing the antigen 
is left in the syringe for more than a very brief period, the antigen can attach to the wall of the syringe and 
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will not be injected into the SP’s forearm, making the test ineffective. Antigen in vials also become less 
effective if exposed to heat or light for more than a brief period. 
When a new vial is needed, retrieve it from the stock antigen box in the laboratory 
refrigerator. Label it with your initials and the date opened. Discard open vials 30 days after opening. 
When a vial is taken from the phlebotomy refrigerator to fill a syringe, check its expiration date and lot 
number. Enter the FDA lot number and expiration date into the computer system. Label the syringe with 
the time the syringe was filled. 
Store one opened vial of the antigen in its separate antigen tray in the phlebotomy and TB 
refrigerator. The phlebotomy and TB refrigerators will contain a thermometer for temperature monitoring. 
The thermometer unit measures the temperature of the liquid in the bottle. 
The syringe may be filled before the phlebotomy or TB exam (prefilled) and kept with the 
vial used to fill the syringe in the tray in the refrigerator. Mark the syringe with time filled and discard if 
not used in 20 minutes. 
3.3.2 Quality Control Procedures 
At the start of every session, record the phlebotomy refrigerator temperature and the TB 
refrigerator temperature in the TB Quality Control Checks. This is found under the Utility tab of the TB 
module (Exhibit 3-1). 
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Exhibit 3-1. TB Quality Control Checks screen 
3.4 Procedures Preceding Skin Testing 
Check that at least one forearm is available for administration of tuberculin tests. Place the 
skin test antigen in the volar surface (palm up side) of left forearm or if left forearm is unavailable, use 
right forearm. A forearm is considered unavailable only if (1) the forearm has been amputated; (2) the 
forearm is completely covered with a cast; (3) the entire surface of the forearm is severely scarred or 
covered with a rash or burn; or (4) there is a medical order not to place injections in the forearm. 
After determining that the SP is eligible for testing (see Section 3.4.1), place the skin test on 
the left forearm, if available. If only one forearm is available, place the skin test on the available forearm. 
If neither forearm is available, exclude the SP from participating in the skin testing component. 
3.4.1 Screening SPs for Skin Test Eligibility 
Ask each SP whether the SP has experienced a previous severe reaction to a skin test 
antigen. Read the exclusion question exactly as it is displayed on the computer screen: “Have you ever 
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had a severe reaction to a TB (Tuberculosis) skin test?” Do not consider a history of a previously positive 
reaction, a large induration, swelling, or redness at the skin test site as severe reactions, and do not 
exclude the SP from the skin testing component. Exclude SPs who report a previous severe skin test 
reaction from the TB skin testing component. A previous severe reaction to tuberculin antigen is an 
anaphylactic response (severe allergic reaction involving the whole body) and/or ulceration at the skin test 
site. Persons who are not available 46-76 hours later during the reaction measurement period are also 
excluded from skin testing. Refer SPs with questions to the NHANES physician. 
3.5 PPD Antigen Skin Testing 
3.5.1 Background: How PPD Antigen Skin Tests Work 
Purified protein derivative (PPD) is extracted from killed bacteria, which have been purified 
and filtered so that only harmless protein fragments, called antigens, remain. Antigens cannot infect 
people or cause disease. However, if a person has been infected with the bacteria at some time in the past, 
the body can recognize the antigens and mount an immune response. After a previously infected person 
has had the appropriate antigen placed just under the skin, a small local reaction in that area, signaling 
that the body has recognized the skin test antigen is usually seen 2 to 3 days later. Testing requires two 
visits, one to place the antigen, and one to measure the skin reaction.  
3.5.2 Skin Test Preparation Steps: Filling Syringes  
1. Locate antigen vial tray on the top shelf of the phlebotomy refrigerator. 
2. Fill the syringe using the technique described below: 
- If needed, open a new antigen vial. Remove the metal cap from the vial. Mark 
the label with date opened and your initials.  
- For a previously opened vial, verify that today’s date is earlier than the 
expiration date recorded on the vial when it was opened. (If today’s date is later 
than the expiration date, discard the vial and obtain a new vial.) 
- Rotate or roll the vial back and forth gently to mix the antigen. Do not shake 
the vial or place it on the tube rocker. 
- For each use, cleanse the top of the vial with an alcohol wipe. 
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- Remove the needle guard. 
- Draw 0.1 milliliter of air into syringe (not more). 
- Inject air into the vial airspace (not the solution). With the vial resting on the 
table, hold the vial between the thumb and fingers of the non-dominant hand 
and insert the needle through the rubber stopper into the air space. Injection of 
air into the air space in the vial prevents creation of negative pressure within the 
vial, allowing antigen to be withdrawn easily. Injecting air into the solution 
creates bubbles and may interfere with withdrawing the correct amount of 
antigen (Figure 3-1). 
- Fill the syringe. Draw slightly more than 0.1 ml of antigen into the syringe by 
pulling back on the plunger with the vial inverted (Figure 3-1). 
- Remove the needle from the vial. 
- Remove excess volume/air bubbles from the syringe. Leave exactly 0.1 ml 
antigen solution in the syringe. Hold the syringe in an upright position and tap 
the barrel lightly to break up air bubbles. Draw back slightly on the plunger and 
push forward. Expel all air and excess fluid from the syringe and needle. 
Replace the needle guard unless the antigen is to be placed immediately. 
(See Figure 3-1.) 
3. Return the antigen vial tray to the phlebotomy or TB refrigerator. 
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Figure 3-1. Syringe filled with exactly 0.1 ml antigen 
Fill the syringe with antigen. (A) Inject a small amount of air (less than 0.1 ml) into the vial 
air space. (B) Invert the vial and withdraw slightly more than the 0.1 ml dose by pulling back on the 
plunger. Separate the syringe from the vial and remove air bubbles. Push plunger to the 0.1 ml line, 
completely filling the syringe and needle with the antigen. The filled syringe should contain exactly 0.1 
ml of PPD antigen. 
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3.5.3 Skin Test Administration Steps 
Procedures for administering the skin test antigen follow. Note, that immobilization of the 
the forearm of young children will be needed. Have a medical technologist hold the child securely while 
the phlebotomist gently but firmly immobilizes the forearm. 
1. Fill the syringe with the Antigen. 
- After phlebotomy, remove the antigen vial tray with syringe from phlebotomy 
refrigerator. Remove the filled syringe from the tray and replace the antigen 
vial tray in the phlebotomy refrigerator. Check that no more than 20 minutes 
have elapsed since the syringe was filled. (If more than 20 minutes have 
elapsed, discard the syringe in the puncture-resistant container and fill a new 
syringe according to the steps in Section 3.5.2.). 
2. Selecting and cleaning the injection site 
- Select injection site on the left inner forearm with the palm up, at least 2” 
from the elbow, wrist, or other injection site as shown in Figure 3-2. 
- Avoid areas over veins; avoid sites that have lesions, heavy hair, bruises, 
scars, a muscle ridge, or tattoos. 
- Clean the injection site with an alcohol wipe using a circular motion 
beginning in the center and working toward the outside. Allow the area to dry 
thoroughly. 







Figure 3-2. TB skin test placement sites  
Administer antigen in the standard site: left inner forearm, if available, with the palm up, at 
least 2” from the elbow, wrist, or other injection site. Avoid areas over veins; avoid sites that have lesions, 
heavy hair, bruises, scars, a muscle ridge, or tattoos. 
3. Inserting the needle and injecting the antigen - Intradermally (just beneath the skin 
surface) inject 0.1 ml of PPD antigen on the volar surface of the forearm with the 
1/2”, 27 gauge short beveled needle just beneath the skin surface with needle bevel 
up to form a small round wheal (at least 6 mm in diameter) at the injection site 
(Figure 3-3). 
Rest the SP’s forearm on a firm, well-lit surface. 
Stretch the skin slightly over the site. This creates a firmer surface for needle 
insertion. 
Hold the needle with the bevel up, 5° to 15° angle to the skin. 
Insert the needle into the superficial layer of skin so that needle tip is visible 
beneath the skin surface. 
Advance the needle until entire bevel lies just under the skin. 
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- Release the stretched skin. Refer to Figures 3-4 and 3-5 for incorrect needle 
insertion positions. 
- Slowly inject the entire dose (0.1 ml antigen) forming a tense skin elevation 
(wheal) at least 6 mm in diameter (See Figure 3-3). 
- Use TB ruler to measure the wheal. An adequate wheal is considered to be > 
that 6 mm. 
- If an adequate wheal does not appear, re-administer the test at least 2 inches 
from the original site. 
- Remove the needle without pressing or massaging the area. 
- Engage the shielding needle guard and discard the used syringe immediately 
in the designated puncture-resistant container. 
- Lightly blot injection site with a 2x2 gauze pad or cotton ball if a drop of 
blood appears.  
- Discard contaminated gauze and used gloves according to NHANES 
procedures. 
- Wash hands. 
- Follow appropriate NHANES emergency procedures if unexpected reactions 
occur as skin tests are being placed. 
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Figure 3-3. Correct skin test placement 
Correct insertion: (A) Stretch the skin to make it taut at the site of injection. Hold the needle 
with the bevel up at a 5°-15° angle to the skin. Insert the needle into the dermis layer beneath the skin 
surface so that the needle tip is visible beneath the skin surface. Advance the needle until the entire bevel 
lies just under the skin. (B) Release the stretched skin. Support the needle and inject exactly 0.1 ml PPD 
antigen just beneath the skin surface, forming a small flat, anemic bleb or wheal (at least 6 mm in 
diameter). 
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Figure 3-4. Incorrect skin test placement 
Incorrect insertion into subcutaneous tissue occurs with an injection angle of greater than (>) 
15°. No wheal will form because the antigen is administered too deeply. 
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Figure 3-5. Incorrect skin test placement 
Incorrect insertion occurs when the needle bevel is not completely inserted into the layer 
beneath the skin surface (dermis). This incorrect needle insertion position can cause leakage of antigen 
preventing the formation of a proper wheal. 
3.6 Appointments for Measurement of Skin Reactions 
Make an appointment for the measurement of the skin reaction to the test 46–76 hours after 
placing the skin test. Skin test readers may not conduct measurements outside this 30-hour window. 
Attempt to schedule the SP for the first appointment available 48 hours after administration of the skin 
tests. Make every effort to schedule appointments between 48 and 52 hours after administration of the 
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skin test. This allows the TB field readers approximately 24 hours to contact and obtain results on SPs 
who do not show up for their scheduled appointment. 
The phlebotomist makes an appointment for the SP to return to the field office after placing 
the skin test antigen. The MEC coordinator gives SPs reading appointment reminders and maps to the 
field office when they check out of the MEC session. Information on all scheduled appointments is sent 
and received electronically at the field office. The TB field readers are responsible for contacting each SP 
to confirm the appointment date and time. The TB readers attempt to reschedule the appointment in the 
SP’s home when the SP does not show up at the field office or MEC for a scheduled appointment. 
The phlebotomist makes every effort to encourage SPs to have their skin test results 
measured in the field office. SPs are paid $40 if they return to the field office and $15 if the measurement 
of skin reaction is conducted in the SPs’ homes. SPs are also paid transportation costs (taxicab or 
mileage) for travel to and from the field office. The appointment card includes information about all of 
the SPs’ follow-up appointments. The SPs’ check-out packets include directions to the field office, where 
their skin test results will be read. 
The final screen of the TB placement application explains that mild itching, swelling, or 
irritation may occur and that these are normal reactions, which do not require any treatment. These 
normal reactions usually subside within a week or earlier. The phlebotomist reads aloud the instructions 
that are displayed on the phlebotomist’s computer screen. These instructions remind SPs that they should 
avoid scratching their forearms and avoid placing anything (e.g., creams, lotion, or medication) on the 
site. SPs may wash their forearms lightly with mild soap and water without pressure. Immediately after 
placement, they should not touch or cover the wheal until it absorbs naturally; this occurs in about 10 
minutes. 
No immediate adverse reactions were recorded when skin tests using the same antigens were 
injected into the forearms of thousands of participants in NHANES I, and no such reactions are expected 
during the present survey. However, there is a theoretical possibility that anaphylactic shock can occur 
when any foreign substance is injected or ingested. If anaphylactic shock should occur after the injection 
of a skin test antigen, follow the procedures in the Emergency Procedures Manual, and report the 
occurrence to Dr. Kathryn Porter using the Adverse Reaction Form. 
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3.7 Entering Results in ISIS  
The TB introduction screen displays after the Venipuncture Status screen (Exhibit 3-2). 
When finished reviewing the Phlebotomy Status screen, use the mouse to select the bright 
blue arrow in the bottom right hand corner to progress to the next section (TB) or select [Enter] when this 
blue arrow is highlighted. 
Exhibit 3-2. Phlebotomy status screen 
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The TB Safety Exclusion Screen displays (Exhibit 3-3). 
Exhibit 3-3. TB safety exclusion screen 
Complete the forearm examination as described in Section 3.4. Proceed to record the 
observation. 
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Record the forearm observation (Exhibit 3-4). 
Exhibit 3-4. Recording the forearm observation 
To record the observation, use the mouse to direct the mouse arrow to the arrow on the drop-
down list and click on your choice. 
If neither forearm is available, the remaining parts of the introduction screen remain 
disabled. To move to the next screen, move the mouse to the bright blue arrow in the bottom right hand 
corner and click on it or select [Enter] when this blue arrow is highlighted. 
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Read the text under the Record Examiner Observation box aloud to the SP (Exhibit 3-5). 
Exhibit 3-5. TB skin test question 
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Read the safety exclusion question and record the response (Exhibit 3-6). 
Exhibit 3-6. Recording response to safety exclusion question 
Record whether or not the SP has had a previous severe reaction; this is defined as ulceration 
at the site or an anaphylactic reaction (allergic reaction involving the whole body). Read the exclusion 
question exactly as it is displayed on the computer screen: “Have you ever had a severe reaction to a TB 
(tuberculosis) skin test?” Do not consider a history of a previously positive reaction, a large induration, 
swelling, or redness at the skin test site severe reactions, and do not exclude the SP from the skin testing 
component. 
To record the response, move the mouse to the drop-down list and click on desired choice. 
Alternatively, to record the response, type the first letter of the correct choice and [Tab.] For example, 
type [Y/y] for “Yes” or [N/n] for “No.” 
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After recording a positive response, the remaining part of the introduction screen remains 
disabled. To move to the next screen, move the mouse to the bright blue arrow in the bottom right hand 
corner and click to select or select [Enter] when this blue arrow is highlighted. 
Read the script to all SPs who report a negative response (Exhibit 3-7). 
Exhibit 3-7. Script for negative responses 
If the SP has not had a previous severe reaction to a skin test antigen, read the test 
description script. To move to the next screen, move the mouse to the bright blue arrow in the bottom 
right hand corner and click to select or select [Enter] when this blue arrow is highlighted. 
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Record the Lot # and Expiration Date for the Tubersol antigen (Exhibit 3-8). 
Exhibit 3.8. Lot # and expiration date for antigen 
Verify the existing Antigen information. The lot # and expiration date defaults to the last 
entry. To change either the lot # or the expiration date, use the numeric keyboard keys to type the correct 
information when the box is highlighted. Select [Tab] to move to the next box. Enter the date format as 
mm/dd/yyyy. 
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Select the arm to which the Tubersol antigen was applied (Exhibit 3-9). 
Exhibit 3-9. Recording arm where antigen applied 
Store skin test antigen in a monitored-temperature refrigerator except when removing the 
antigen to fill the syringes. Do not allow filled syringes to stand for more than 20 minutes before use. 
Follow procedures described in Section 3.5. 
To record the results of the Tubersol antigen application, move the mouse to the arrow on 
the drop-down list and click on the desired choice. Alternatively, to record the response, type the first 
letter of the correct choice and [Tab]. For example, type [Y/y] for “Yes” or [N/n] for “No.” 
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If the “No” or “No antigen available” option is selected for the Tubersol, the lot information 
will remain disabled (Exhibit 3-10). 
Exhibit 3-10. Verifying antigen information 
Use a CDC approved/calibrated ruler to measure the size of the wheal given during Tubersol 
placement. Record result in TB placement screen (Exhibit 3-11). Choices are <6, 6, 7, 8, 9, 10 and >10. If 
the wheal is less than 6, place another TB skin test because not enough antigen was placed to be 
considered a valid test. 
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Exhibit 3-11. Documenting the size of the wheal 
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Schedule the SPs reading (measurement) appointment (Exhibit 3-12). 
Exhibit 3-12. TB reading appointment 
The appointment screen displays a list of SPs including the SP who just received the skin 
test(s) and any other family members who are also SPs in the same MEC session. The SP may make an 
appointment for himself or herself and for any or all other family members. If appointments already exist 
for any SP on the list, this information displays. The SP may change appointments for any or all of the 
SPs on the displayed list. 
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Read the text to the SP and review the available appointment slots (Exhibit 3-13). 
Exhibit 3-13. TB reading appointment time slots 
Read the text, “I now need to make an appointment for you two days from now to have the 
results of this test read” to the SP. 
Display the preferable appointment time slots for which the SP is eligible, displayed in green 
font. Attempt to schedule SPs for sessions 48-52 hours from the current time, which are displayed in a 
green font. If none of these times are suitable for the SP, check the Show All box to display the expanded 
schedule. Time slots with a yellow font are next desirable appointments after the green slots. The yellow 
font time slots represent the 52-72 hours group of appointments. The red font represents the least 
desirable appointments in the 46-48 hour group and the 72-76 hour group. 
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Select the time slot (Exhibit 3-14). 
Exhibit 3-14. Selection of time slot 
To select a time slot, click the box under Schedule that corresponds to the date and time of 
interest. 
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Attach a reason for SPs who refuse to make an appointment (Exhibit 3-15). 
Exhibit 3-15. Reason for refusing appointment 
If the SP refuses to schedule an appointment, indicate the SP’s request by leaving the 
Schedule box empty, placing a check mark in the Not Scheduled box and selecting the appropriate 
comment. To select the appropriate comment, move the mouse to the arrow on the drop-down list and 
click on the desired choice. ISIS transmits all scheduling information to the field office. The TB field 
readers contact the SP to schedule the appointment. To move to the next screen, move the mouse to the 
bright blue arrow in the bottom right hand corner and click, or select [Enter] when this blue arrow is 
highlighted. 
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Review the instructions with the SP. 
The TB Reminder Card informational message window displays (Exhibit 3-16). Read these 
instructions to the SP. Answer any questions or concerns. To progress to the TB section status screen, 
move the mouse to the bright blue arrow in the bottom right hand corner and click to select. 
Exhibit 3-16. TB Reminder Card 
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Review the TB section status (Exhibit 3-17). 
Exhibit 3-17. TB status review 
The TB status is complete if the antigen was applied, partial if the SP needs to be re-assigned 
to the TB component, and not done if the SP was excluded or the antigen wasn’t placed. If the SP was 
excluded as a result of a “Yes” response to the question, “Have you ever had a severe reaction to a 
tuberculosis (TB) skin test?” enter the “Safety Exclusion” comment in the Comments text box. 
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Use comment codes to explain Partial and Not Done statuses (Exhibit 3-18). 
Exhibit 3-18. TB status with comment codes 
Choose and enter the appropriate comment code when the TB section status is partial or not 
done (Exhibit 3-19). To record a comment in the Comments text box, move the mouse to the scroll arrow 
on the drop-down list and click on the desired choice. Use the scroll bar to view all choices. Alternatively, 
use the up and down keyboard arrows to scroll through the choices or type the first letter of the desired 
comment code. 
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Exhibit 3-19. List of comment codes and when used 
Comment Code Use when: 
Safety exclusion SP has had a previous severe reaction to a TB test. 
SP refusal The SP refuses to have the antigen administered. This is SP initiated 
nonresponse due to refusal. The SP refuses the component or a part of the 
component for any reason other than an illness or emergency. If the SP refuses 
in the reception area, the coordinator codes the exam. If the SP refuses after 
starting the exam, the examiner codes the exam. 
No time Not applicable 
Physical limitation SP is unable to have the test due to a physical problem. 
Communication 
problem 
SP is unable to understand and follow instructions for the component due to 
language, cognitive impairment, or other problem, and is unable to complete 
the test. 
Equipment failure Not applicable. 
SP ill/emergency The SP became ill or an emergency occurred and the test could not be 
performed on the SP. 
Interrupted The exam is interrupted, usually for a MEC-wide emergency, and cannot be 
completed by the SP. 
SP did not meet fast Not applicable 
Other, text If the above reason for a status Code of Not Done is not explained by one of 
the Comment Codes, the examiner must choose Other, text and record a 
comment in the text field. 
When finished, use the mouse to direct the mouse arrow to the bright blue arrow in the 
bottom right hand corner and left click to progress to the end of the exam or select [Enter] when this blue 
arrow is highlighted. 
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3.8 Conducting the TB Exam in Spanish 
When the phlebotomist must administer the TB procedure to a SP who does not speak 
English and the phlebotomist does not speak the language of the SP, a translator who does speak the 
language of the SP assists the phlebotomist. 
The translator stays with the phlebotomist and the SP for the entire procedure. It is very 
important that the phlebotomist be able to communicate with the SP if the SP becomes ill during the 
examination. 
Convert the phlebotomy interview and fasting questionnaire text from English to Spanish or 
from Spanish to English at any time before, during, or after an exam. 
To view the scripts in Spanish, move the mouse to {Utilities} in the menu bar, click on 
{Spanish}, or type [Ctrl] [S]. 
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All scripts display in Spanish (Exhibit 3-20). 
Exhibit 3-20. TB safety exclusion-Spanish 
To return the scripts to English, move the mouse to {Utilities} in the menu bar, click and 
select {English}, or type [Ctrl] [E].  
3.9 Severe Adverse Reactions during Antigen Administration 
No immediate adverse reactions were recorded when skin tests using the same antigen were 
injected into the forearms of thousands of participants in NHANES I and no such reactions are expected 
during the present survey. However, there is a theoretical possibility that anaphylactic shock can occur 
when any foreign substance is injected or ingested. If anaphylactic shock should occur after the injection 
of a skin test antigen, complete an incident/emergency form for severe placement reactions (see Exhibit 3-
21). Follow the procedures in the Emergency Procedures Manual. The occurrence must also be reported 
on the Adverse Reaction form, which is generated in the physician application, to Dr. Kathryn Porter. 
Email to Dr. Porter immediately. 
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Exhibit 3-21. MEC Incident/Emergency Report form 
Public Health Service 
Centers for Disease Control and Prevention 
National Center for Health Statistics 
5525 Belcrest Road 
Hyattsville, Maryland 20782 
MEC INCIDENT/EMERGENCY REPORT 
  




SP Tech Other 
General Information 
Physician Name:  Recorder Name: 
Emergency Date: Runner Name(s): 
Start Time:  End Time: Who Called 911: 
Location: Who Found:  
Description: 
Personal Information 
Person ID: Age: Gender:  
Last Name:  First Name:  Middle Name: 
DEPARTMENT OF HEALTH & HUMAN SERVICES 
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Exhibit 3-21. MEC Incident/Emergency Report form (continued) 
















      
      
      
      
      
      
      
      
      
      
Treatment 
Time Medication/Equipment Comment 
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Exhibit 3-21. MEC Incident/Emergency Report form (continued) 












 ___________________________________________________________________________________  






Exhibit 3-21. MEC Incident/Emergency Report form (continued) 
MEC INCIDENT/EMERGENCY REPORT 
 
   
______________________________________________________________________________ 
 Page 4 of 5 
Urgent Care 
 Transported to Hospital Hospital Name: 
Ambulance Arrival Time:  Ambulance Departure Time: 
Emergency Service Name: 
 Physician Accompanied SP to Hospital 
Notification 
 Family Member Notified Name: Date/time: 
Relation: 
 Family Physician Notified Family Phys Named: Date/time: 
Signature:      Date:   
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Exhibit 3-21. MEC Incident/Emergency Report form (continued) 












      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
DEPARTMENT OF HEALTH & HUMAN SERVICES 
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4. TUBERCULOSIS SKIN TEST READING PROTOCOL 
4.1 Overview 
Primary sample persons (SPs) aged 6 years old and over who meet the inclusion criteria are 
eligible for testing for TB infection with the tuberculin skin test (TST). In the MEC, the examiner 
(phlebotomist, medical technologists, and physician) injects 0.1 ml Tubersol antigen in the left forearm of 
the eligible SP and schedules a reading appointment with a specific reader in 15-minute increments 48-52 
hours after placement. The TB Placer can expand the list of available appointments to 46-76 hours if the 
SP indicates that he or she is not available during the ideal reading window. It is extremely important to 
complete the reading during the ideal window of 48-72 hours. Only under rare situations should the 
reading occur between 46-48 or 72-76 hours from placement. 
Six trained full-time TST readers read the TST result or measure the area of induration using 
a millimeter (mm) ruler. Enter all results into the TB Reader application. 
TST readers conduct most TST readings in the field office. The readers make reminder calls 
and are also responsible for traveling to SP’s homes to read the TST results of SPs who cannot or will not 
return to the field office. After the stand closes, conduct TST readings in a designated room in the staff 
hotel. If the TB Reader application is unavailable, record the data on the TB Reading Form (Exhibit 4-27) 
and enter the data once the application is available. 
When the participant checks out of the MEC on the last few exam days, the coordinator 
gives the SP a hard-copy packet of informational material, including a reminder with the TB appointment 
date and time and a map to either the field office or to the staff hotel. 
Participants receive $40.00 if they come to the field office or to the hotel to have their TST 
results read within the 46–76 hour timeframe. Arrange for free transportation to the office or hotel or 
reimburse the participant for transportation expenses. Participants who are unable to go to the field office 
can have their test read at home and they receive $15.00. 
SPs receive either an automated printout or a written copy of their TST result at the time of 
the reading. Persons with a positive TST result (defined as induration greater than 10 mm) will be referred 
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to a community physician or local health department. The result will also be included in the Final Report 
of Findings sent to participants 12–16 weeks after the TST. Parents/guardians of minors under the age of 
18 will be given the findings and, if indicated, the referral for their child(ren). 
As noted earlier, a TST result must be read between 46 and 76 hours after administration 
placement of the TST. If the SP misses the field office reading appointment, contact the SP so that the 
reading can be completed in the office or the home before the 76-hour time limit is reached. Do not read 
skin tests if the time since the administration of the antigen exceeds 76 hours.  
Two or more TST readers should read SP’s reactions for Quality Assurance (QA) purposes 
for at least 25 percent of all readings. For these blinded independent duplicate readings (BIDRs), TST 
readers neither consult nor observe one another’s readings. When a BIDR is performed, record results 
independently. Results may be discussed after both readers have recorded their results, but results cannot 
be changed. Gold standard readers (GSR) are designated by the Centers for Disease Control and 
Prevention, Division of TB Elimination, and visit NHANES sites for quality assurance purposes on a 
quarterly basis. Supervised readings may also take place, in which one or more TST readers read the 
results and discuss with a GSR. Discussion and coaching may take place during this type of reading but 
only one result is recorded. 
Enter TB reading measurements directly into the TB Reader application at the time of the 
reading. The application automatically generates a Report of Findings (ROF) with the TST result. The 
ROF lists a “positive” or “negative” result for the test. Print and give the ROF to the SP at the time of the 
reading. When conducting readings in SP homes, complete a written report and give the report to the SP. 
For those who have a positive TST result, provide the address and phone number for the local health 
department.  
Do not discuss findings while measuring and recording TST results. If the SP asks for 
findings before readings are completed, explain that the results can be discussed only after the computer-
generated ROF reveals the result.  
If a severe reaction is observed (ulcer, vesiculation, anaphylactic shock), complete an 
Adverse Reaction Form and email it to Dr. Kathryn Porter at NCHS. 
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4.2 Equipment and Supplies 
The equipment and supplies required to measure skin reactions are listed below. Note that 
some nonconsumables remain with the field office, readers hand carry a subset of supplies from one stand 
to the next, while other supplies are restocked by the warehouse, and many forms are printed on site. Send 
all rulers and receipts to the home office supervisor after all SPs have been read. Record zero on the end 
of stand inventory sheet for these two items.  
The makeup bag, light, money bag, and calculator travel with the readers from one site to the 
next. Record the count as “3” on the end of stand inventory sheet. A subset of consumable supplies also 
travels with the readers from one stand to the next; these are used for hotel and home readings after the 
stand closes. This includes the pencils, gauze, small baby oil bottle, ROF envelope, and money envelope. 
Account for these on the end of stand inventory sheet or the start of stand numbers will be off for the next 
team.  
Nonconsumables 
Stay with the Field Office Staff 
Par Level 
Incandescent flexible-neck lamp 3 
Locking money drawer 3 
Stapler standard size 3 
Tape dispenser, Scotch 3 
Trash cans, 15” 3 
Nonconsumables 
Travel with TB reader to Each Stand  
Par Level 
Reader light portable  
(for home readings) 
3 
Calculator with large keys  
(to calculate transportation costs, mileage, etc.) 
3 
Zippered bag  
(for money) 
3 
Cosmetic bag  
(for home exam supplies) 
3 
Consumables from Warehouse Par Level 
Cosmetic fine-tipped pencils, black 9 
2 x 2 Nu gauze 6 pkgs 
(200/pkg) 
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TB reading rulers 12 
Baby oil in small dropper bottle 6 
Baby oil bottle 1 
Tape, 3/4” Scotch 3 
Box of staples 3 
Large white envelope  
(for Report of Findings) 
500 
Money envelopes  400 
Purell handsoap 3 
Reminder card 40 
Hard-Copy Forms (Print Onsite) Par Level 
Adverse Reaction 
(Should send by email but may need to fax) 
20 
Hard-copy data entry 40 
Adult ROF-TB Neg 
English 
40 
Adult ROF-TB Neg 
Spanish 
20 
Adult ROF-TB Pos 
English 
40 
Adult ROF-TB Pos 
Spanish 
20 
Child ROF-TB Neg 
English 
40 
Child ROF-TB Neg 
Spanish 
20 
Child ROF-TB Pos 
English 
40 
Child ROF-TB Pos 
Spanish 
20 
Receipt Calculation and Signature Form 200 
Name, address, and contact phone number for the local 
health department. 




4.3 Procedures for Reading TST Results 
 Preliminary Procedure 
 Keep fingernails sufficiently short so that they do not protrude beyond the finger. 
 Set up the computer and supplies in a well lit area, turn on the lamp, and support the 
arm being examined. 
 Sharpen marking instrument (eyeliner pencil) to make a small, fine dot so that the dot 
is easily removed without friction. 
 Introduce yourself to the SP and briefly explain the procedure. 
 Confirm the identity of the SP and match it against the information on the computer 
screen. 
 Read the correct forearm. The TB Reader data entry screen indicates whether the 
antigen was placed on the right or left forearm. 
Ensure that the setting for reading is suitable and that equipment and supplies are at hand 
before a reading begins. TB readers introduce themselves and explain that the TB skin test measurement 
consists of examining the SP’s arm to locate, mark, and measure any reaction. Inform the SP that the 
result is recorded in the computer and that the computer generates a report of the results after the 
examination.  
Verify the identity of the SP before beginning the examination of the arms. All SPs received 
an appointment reminder when they exited the MEC. This document lists the SP’s name. TB readers must 
rely on the person escorting the SP to the reading site to correctly identify younger SPs. Confirm the SP’s 
identify and verify that the information contained on the application result screen is identical. 
Have the SP sit in a well-lit area and provide arm support. Begin the examination on the arm 
that is designated on the TB Reader screen. This will be the right arm unless otherwise documented. After 
locating the site, rely on palpation (touch) with the fingertips to determine whether induration (a hard 
dense raised reaction) is present. Keep fingernails sufficiently short so that they do not protrude beyond 
the finger in order to read the result properly. (Figure 4-1). 
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Figure 4-1. Correct and Incorrect Fingernail Length for Palpation Method 
A. Maintain fingernails sufficiently short so that they do not protrude beyond the fingertip in 
order to read the result properly. 
B. Nails should not be visible above the tips of the fingers. 
C. Nails should not be long and sharp. 
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Reactions to the antigen at the injection site range from no induration to a large, hard density 
in the skin. Only measure induration; if no induration is present, do not measure. Do not measure redness 
(also called erythema) and soft swelling. If induration is present, further palpate to locate the margins of 
induration transverse to the long axis of the forearm. Touch the area lightly with the pads of the fingertips 
with fingers together, using a light gentle motion (Figure 4-2). When palpating for margins, take care not 
to confuse a margin of induration with a margin of muscle on the forearm. If there is no hard density, 
record a 0 (zero) result even if other skin changes such as redness or soft swelling are noted. 
If one margin of induration is definitely palpable, it is necessary to mark the margins on 
either side of the induration, even if the margin is not equally clear all the way around the area of hard 
denseness (Figure 4-3). Even if the area of induration is small, mark the margins and measure the area of 
hard density transverse to the long axis of the arm. Lightly mark each of the two sides of the induration 
with a dot (Figure 4-4). Do not mark other skin changes such as redness or soft swelling. If the margins of 
induration are irregular, mark and measure the largest diameter transverse to the long axis of the arm 
(Figure 4-5). The correct placement of the ruler is illustrated in Figure 4-6 and the incorrect placement of 
the ruler is illustrated in Figure 4-7. 
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Touch the area lightly with the pads of the fingertips with fingers together, using a light 
gentle motion. 
Figure 4-2. Palpating to Find the Borders of the Induration 
Palpate to find the margins (borders) of induration transverse to the long axis of the forearm. 
With the SP’s forearm bent 90° at the elbow, supported on a hard surface, lightly sweep the fingertips 
over the volar (palm up) surface of the forearm, and outline the margins of induration. 
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If one margin of induration is definitely palpable, it is necessary to mark the margins on 
either side of the induration, even if the margin is not equally clear all the way around the area of hard 
denseness. 
Figure 4-3. Marking the Margin Points at Either Side of the Widest Area of Induration 
Transverse to the Long Axis of the Forearm 
A. Hold palm over the injection site with fingertips at the outer edge of the arm.  
B. Without lifting, move the fingertip from the outer edge of the arm towards the induration. 
Rest the finger firmly against the induration margin border on one side before marking 
(fingertip remains in contact with skin at all times). 
C. Mark lightly with a fine dot at the widest edge of the induration, using the fingertip as a 
guide. Repeat procedure to place second mark on margin of induration. 
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Lightly mark each of the two sides of the induration with a dot. 
Figure 4-4. Correct Marking of the Points on the Margins of Induration 
A correct marking - shows fine dot marks on two sides of the induration transverse to the 
long axis of the forearm. 
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Do not mark other skin changes such as redness or soft swelling. 
Figure 4-5. Incorrect Marking 
An incorrect marking - shows fine dot marks on two sides of the redness or soft swelling 
transverse to the long axis of the forearm. Only mark hard density (induration). 
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Correct ruler placement. 
Figure 4-6. Correct Placement of the Millimeter Ruler to Measure the Induration 
TST result: 12 millimeters (mm) 
Measure a TST result with the millimeter ruler. Place the zero millimeter ruler line inside the 
left dot edge. Read the ruler line inside the right dot edge. If the measurement falls between two divisions 
on the millimeter scale, record the lower mark. 
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Incorrect ruler placement. 
Figure 4-7. Incorrect Placement of the Millimeter Ruler to Measure the 
Points on the Margins of Induration 
This is an incorrect ruler placement. The zero ruler line is incorrectly placed on the edge of 
redness instead of on the mark. 
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If a SP asks about the test findings during the examination of the arms, explain again that the 
findings must wait until the computer generates the ROF. After recording all results, the Report of 
Findings prints; read the text to the SP. Refer questions that cannot be answered by repeating the 
information printed on the ROF to Dr. Kathryn Porter. 
4.3.1 TST Protocol 
Using good light, carefully inspect the volar (palm up) surface of the forearm to locate the 
site of injection. Focus the palpation in this area. 
 Palpate to Find the Margins (borders) of Induration 
 Lightly sweep the fingertips over the entire volar surface of the forearm to confirm the 
position of the injection site. 
 Lightly sweep 2” diameter from injection site (four directions) to locate any area of 
induration (hard raised density) and to differentiate induration from muscular soft 
swelling. 
 Use zigzag feather-like touch over the area of induration to outline the margins of 
induration. If the injection site is near a muscle margin, do not confuse the muscle 
margin with a margin of induration. Mentally note the provisional location of the 
margin points at either side of the widest area of induration transverse to the long axis 
of the forearm (Figure 4-2). 
 Repeat the palpation method with forearm bent 45° at elbow to determine effect of 
position on the margin points (Figure 4-2). 
 Hold palm over injection site with fingers transverse to the long axis of the forearm 
(see Figure 4-3). 
 Move fingertips lightly on skin toward injection site. 
 Maintain the arm in the position at which the margins are most clearly palpable in 
order to mark them. Once more, locate the position of margin points at either side of 
the widest area of induration transverse to the long axis of the forearm and proceed to 
marking. 
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 Mark the Margin Points at Either Side of the Widest Area of Induration Transverse to 
the Long Axis of the Forearm (Figures 4-3 and 4-5) 
 Palpate with forearm bent 90° at elbow.  
 If the palpation revealed that the margin bordering one side of the induration was 
more definite than that on the other side, begin the marking procedure on that side. 
 Without lifting finger, pull fingertip tight against the margin bordering the area of 
induration on one side before marking (fingertip remains in contact with skin at all 
times) (see Figure 4-3). 
 Place single dot on skin at margin point (Figure 4-3 shown earlier). 
 Repeat the procedure on the other side of the induration. 
 If margin is indefinite on one side, follow the margin of induration around from the 
side on which it is more definite and place the second dot at the point across from the 
first dot located by this procedure. 
 Inspect dots, repeat finger movement toward margins, and verify dot placement under 
adequate light by confirming that each dot is at the point where the fingertip meets the 
margin. 
 Verification should confirm that dots are located where the distance between the 
points is the widest diameter between the margins of induration that is perpendicular 
to the arm length (Figure 4-4). This means that the two dots are across from one 
another and that an imaginary line drawn between the two dots would be at 90 degrees 
relative to the long axis of the forearm. 
 Figures 4-4 and 4-5 (shown earlier) picture the correct and incorrect placement of dots 
defining the margins of induration. 
 Measure: Placing and Measuring Skin Reactions with the Millimeter Ruler 
 Place the zero ruler line inside the left dot edge. 
 Read ruler line inside right dot edge. 
 If the measurement falls between two divisions on the millimeter scale, record the 
lower mark. 
 Refer to Figures 4-6 and 4-7, shown earlier, for the correct and incorrect placement of 
the ruler for measuring hard density in the skin. 
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4.3.2 Record Measurement on the TB Reader Application 
 Record millimeter measurement of skin reactions correctly. 
 Record measurements between 0 and 86 millimeters as measured. Record 
measurements greater than 86 millimeters as 87+ millimeters. No reaction >86 
millimeters is expected; if such a reaction is recorded, confirm that this is correct and 
complete an Adverse Reaction Form and email the form to Dr. Kathryn Porter on the 
same day. 
4.3.3 Inspect the Volar Surface of Each Forearm for Adverse Reactions 
 Note the presence or absence of other skin reactions such as vesiculation and bullae or 
ulceration and necrosis anywhere on the volar surface of the arm being examined. If 
any of these skin reactions are present anywhere on the volar surface, do not make a 
judgment about whether these are related to the skin test, but record their presence. 
 Identify and record the presence or absence of vesiculations and/or bullae correctly. 
Vesiculation refers to small, fluid-filled, blister-like lesions. Bullae are similar to 
vesiculations but they are larger. 
 Identify and record the presence or absence of ulceration and/or necrosis correctly. 
Ulceration refers to sloughing of damaged skin or a raw, open sore. Necrosis is the 
death of cells because of damage or disease. 
Gently remove dots from forearm after measuring, using baby oil and gauze or cotton pad, or 
using eye makeup remover pad. 
4.4 Quality Control Measurement of Skin Reactions: (BIDRs) 
If performing BIDRs, complete the recording and remove marks from the arms before the 
additional reader enters the area for the reading. Previous readers should not remain in the reading area 
during a BIDR. 
 Enter measurements and then select “Yes” to the QC question in order to obtain the 
blank QC screen before second reader comes into the area. 
 Gently remove dots from forearm after measuring, using baby oil and gauze or cotton 
pad before the second reader comes into the area. 
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 Leave the area while the QC measurement of skin reactions takes place. Do not watch 
the second reading because nonverbal involuntary movements or facial expressions 
may bias the reading of the second reader. 
 The second reader follows the procedure for reading noted above. A QC question also 
appears at the end of the second reader’s readings. If there are no further readings, the 
second reader should select “No” to the QC question. If another reader is to perform a 
BIDR, the second reader should select “Yes.” 
4.4.1 BIDRs by More Than Two Readers 
 Up to eight readers may record readings. This will allow BIDR comparisons between 
multiple pairs of readers (the first and second reader, the second and third reader, and 
the first and third reader, etc.). 
 If an additional reading is to take place, the previous reader should complete his or her 
reading. 
 The previous reader gently removes dots from forearm after measuring, using baby oil 
and gauze or cotton pad before the next reader comes into the area. 
 Leave the area while the QC measurement of a skin reaction takes place. No previous 
reader should watch the next reader because nonverbal involuntary movements or 
facial expressions may bias the reading of the next reader. 
 The next reader should follow the procedure for reading noted above. No QC question 
will appear after the eighth reader completes his or her readings. The report of 
findings prints after all readings are complete. 
4.5 Adverse Reaction Form 
If any skin reactions are present, complete an Adverse Reaction Form (Exhibit 4-1) while the 
SP is present. 
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Exhibit 4-1. Adverse Reaction Report 
NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 
 
TUBERCULOSIS (TB) SKIN TESTING 
ADVERSE REACTION REPORT 
Sample Person (SP) Information 
SP ID:  _____________________________ 
 Insert participant sample number. 
 
TB Skin Test (TST) Information 
Date and Time of Administration: 
|__|__|-|__|__|-|__|__|__|__| |__|__| : |__|__| 
 MM DD YYYY HR MIN 
 AM 
 PM 
Date and Time of Reading: 
|__|__|-|__|__|-|__|__|__|__| |__|__| : |__|__| 



















Report of Findings 
TST result:  Positive 
  Negative 
Comments or descriptions of other adverse reactions: 
 
TST Reader 
Tech ID:  _______________________ 
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Expect a small percentage of minor adverse reactions with some TSTs, including those used 
in NHANES. These usually resolve within a few days. Record ulcerations, necrosis, vesiculations, or 
bullae on the ISIS computer screen. Report all adverse reactions quickly on the Adverse Reaction Form 
(Exhibit 4-8) so that Dr. Kathryn Porter has the necessary information if a SP with such a reaction calls 
her with a question, and email the form to her on the same day. Telephone Dr. Porter at (301) 458-4441 to 
let her know to expect the email. Record the SP’s ID, the date and time, the nature of the reaction, and the 
arm on which the adverse reaction was noted. 
4.6 Report of Findings (ROF) 
After all readings are completed, provide the SP with the ROF. The TB Reader application 
generates this report automatically after the section status screen displays. For measurement of a skin 
reaction conducted in the home, the application indicates whether the result is positive or negative. The 
TB reader manually records this information on the ROF form. 
Read the ROF to the SP. If the SP has questions about the measurement of the skin reaction 
or the ROF, attempt to answer the question by repeating the language of the ROF. If the SP is not 
satisfied, or if the SP has questions that cannot be answered by using the language of the ROF, refer the 
SP to Dr. Kathryn Porter at NCHS. Dr. Porter’s telephone number is listed on the bottom of the ROF. 
If the TST result is less than 10 mm, the SP receives a report indicating that, according to the 
skin test, he or she is not likely to have been infected with TB in the past, but the blood test for TB 
infection is still pending. 
If the TST result is equal to or greater than 10 mm, the SP receives a report indicating that he 
or she may have been infected with TB at some time during the past, but that the blood test for TB 
infection is still pending, and further clinical evaluation is needed. 
If the result is positive, the ROF will automatically include the referral to the local health 
department for further evaluation. Verify that the local health department address and phone number are 
included. 
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Confirm the result on the TB ROF against the computer-generated ROF at the start of each 
stand. Place the ROF in an envelope and hand it to the SP. 
There are two versions of the TB ROF, one for children between the ages of 6 and 17 and 
one for adults, aged 18 years and older. The TB ROFs are shown in the following exhibits: 
 Exhibit 4-2 Adult ROF: test is negative - English 
 Exhibit 4-3 Adult ROF: test is positive - English 
 Exhibit 4-4 Adult ROF: test is negative - Spanish 
 Exhibit 4-5 Adult ROF: test is positive - Spanish 
 Exhibit 4-6 Child ROF: test is negative - English 
 Exhibit 4-7 Child ROF: test is positive - English 
 Exhibit 4-8 Child ROF: test is negative - Spanish 
 Exhibit 4-9 Child ROF: test is positive - Spanish 
4-21 
Exhibit 4-2. Adult ROF: test is negative – English 
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Exhibit 4-3. Adult ROF: test is positive – English 
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Exhibit 4-4. Adult ROF: test is negative – Spanish 
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Exhibit 4-5. Adult ROF: test is positive – Spanish  
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Exhibit 4-6. Child ROF: test is negative – English 
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Exhibit 4-7. Child ROF: test is positive – English 
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Exhibit 4-8. Child ROF: test is negative – Spanish 
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Exhibit 4-9. Child ROF: test is Positive – Spanish 
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Transfer the reading from the TB Reader screen to the Home Visit Tuberculosis Test Report 
of Findings form. If the value is 85 or less, write the value in the space on the form. If the value is greater 
than 86, write “greater than 86” in the space. Place a checkmark in the appropriate Negative or Positive 
check box. 
If the ROF indicates that the test result is negative, explain that, although this test is 
negative, a blood test is still pending. If either the skin or blood test is positive, then the SP should visit 
his or her physician or the local health department. If the test result is positive, explain that it is possible 
the person was infected with the bacteria that cause TB but that clinical evaluation is needed. The ROF 
recommends that if the person has not previously had a positive skin test, he or she should report these 
findings indicating possible infection to the physician so that a clinical evaluation can be performed. The 
ROF also provides the name, address, and telephone number of the local health department where 
evaluation can be performed in case the SP does not have or does not wish to use a private source of 
medical care. Reassure the SP that infected individuals without active TB are not infectious to others, and 
that infection with TB bacteria does not mean the SP “has TB.” However, some infected people need 
treatment to prevent TB and that is why a clinical evaluation is important. Place the report in an envelope 
and hand it to the SP. If the SP wishes to discuss the findings further, refer him or her to Dr. Kathryn 
Porter at the telephone number on the bottom of the ROF. 
Again, if the SP has questions about the TB skin test that was performed, or about the ROF, 
repeat the text displayed in the ROF and refer the SP to Dr. Kathryn Porter at NCHS if the text does not 
answer the question. Dr. Porter’s telephone number is listed on the bottom of the ROF.  
In SP homes, the TB reader transfers the test result to the Home Visit Tuberculosis Test 
Report of Findings form and provides the SP with this copy of the ROF. For positive results, provide the 
additional document that contains the address and contact phone number for the local health 
department. 
There are four versions of the form: Home Visit Tuberculosis Test Report of Findings – 
Adult (Exhibit 4-10) test is negative; Home Visit Tuberculosis Test Report of Findings – Adult test is 
positive (Exhibit 4-11); Home Visit Tuberculosis Test Report of Findings – Child (Exhibit 4-12) test is 
negative; and Home Visit Tuberculosis Test Report of Findings – Child test is positive (Exhibit 4-13). 
There are four Spanish versions of these same documents (Exhibits 4-14 through 4-17). 
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 Exhibit 4-10. Home Visit Tuberculosis Test Report of Findings – Adult: test is 
negative – English 
 Exhibit 4-11. Home Visit Tuberculosis Test Report of Findings – Adult: test is 
positive – English 
 Exhibit 4-12. Home Visit Tuberculosis Test Report of Findings – Child: test is 
negative – English 
 Exhibit 4-13. Home Visit Tuberculosis Test Report of Findings – Child: test is 
positive – English 
 Exhibit 4-14. Home Visit Tuberculosis Test Report of Findings – Adult: test is 
negative – Spanish 
 Exhibit 4-15. Home Visit Tuberculosis Test Report of Findings – Adult: test is 
positive – Spanish 
 Exhibit 4-16. Home Visit Tuberculosis Test Report of Findings – Child: test is 
negative – Spanish 
 Exhibit 4-17. Home Visit Tuberculosis Test Report of Findings – Child: test is 
positive – Spanish 
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Exhibit 4-10. Home Visit Tuberculosis Test Report of Findings – Adult: test is negative – English 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT NEGATIVE 
Participant Name:   Sample Number:   
Date skin test placed:  
  
MM/DD/YYYY 
Date skin test read: 
  
MM/DD/YYYY 
Two tuberculosis (TB) tests were performed as part of the National Health and Nutrition Examination 
Survey: a skin test and a blood test. Results below are for the skin test.  
The results from your blood test will be provided in the Final Report of Findings sent by mail 12–16 
weeks after the examination. If the blood test for TB infection is positive, we will notify you right away. 
 
 Negative 
Based on the skin readings, your test result for TB infection was negative (____mm). This means that you 
probably have not been infected with TB.  
 
If you have any questions, you may call Dr. Kathryn Porter on one of our toll-free numbers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
English: 1-800-452-6115, press “2” Chinese: 1-866-887-7996, press “1” 
Spanish: 1-800-452-6115, press “3” Korean: 1-866-887-7996, press “2” 
  Vietnamese: 1-866-887-7996, press “3” 
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Exhibit 4-11. Home Visit Tuberculosis Test Report of Findings – Adult: test is positive – English 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT POSITIVE 
Participant Name:   Sample Number:   
Date skin test placed:  
  
MM/DD/YYYY 
Date skin test read: 
  
MM/DD/YYYY 
Two tuberculosis (TB) tests were performed as part of the National Health and Nutrition Examination 
Survey: a skin test and a blood test. Results below are for the skin test.  
The results from your blood test will be provided in the Final Report of Findings sent by mail 12–16 
weeks after the examination. If the blood test for TB infection is positive, we will notify you right away. 
 
 Positive 
Based on the skin readings, your test result for TB infection was positive (_____mm). This means that it 
is possible that you were infected with tuberculosis at some time during your life. Most people infected 
with tuberculosis never develop active TB disease. People who are infected but do not have active disease 
cannot spread TB to anyone else. If no one has told you before that you may have been infected with TB, 
we strongly recommend you take this report to your doctor or to the local health department as soon as 
you can. Your doctor or the health department may want to do another test to see if you need medicine to 
prevent active TB disease. The address and contact phone number for further evaluation at your local 
health department is provided separately. 
 
If you have any questions, you may call Dr. Kathryn Porter on one of our toll-free numbers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
English: 1-800-452-6115, press “2” Chinese: 1-866-887-7996, press “1” 
Spanish: 1-800-452-6115, press “3” Korean: 1-866-887-7996, press “2” 
  Vietnamese: 1-866-887-7996, press “3” 
The NHANES survey is a research study. Because no risk factor information was available at the time of 
the reading, a result of 10 mm or more of induration was considered positive. 
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Exhibit 4-12. Home Visit Tuberculosis Test Report of Findings – Child: test is negative – English 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – CHILD NEGATIVE 
Participant Name:   Sample Number:   
Date skin test placed:  
  
MM/DD/YYYY 
Date skin test read: 
   
MM/DD/YYYY 
Two tuberculosis (TB) tests were performed as part of the National Health and Nutrition Examination 
Survey: a skin test and a blood test. Results below are for the skin test.  
The results from your child’s blood test will be provided in the Final Report of Findings sent by mail  
12–16 weeks after the examination. If your child’s blood test for TB infection is positive, we will notify 
you right away. 
 
 Negative 
Based on the skin test readings, your child’s result for TB infection was negative (_____mm). This means 
your child probably has not been infected with TB. 
 
If you have any questions, you may call Dr. Kathryn Porter on one of our toll-free numbers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
English: 1-800-452-6115, press “2” Chinese: 1-866-887-7996, press “1” 
Spanish: 1-800-452-6115, press “3” Korean: 1-866-887-7996, press “2” 
  Vietnamese: 1-866-887-7996, press “3” 
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Exhibit 4-13. Home Visit Tuberculosis Test Report of Findings – Child: test is positive – English 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS - CHILD 
Participant Name:   Sample Number:   
Date skin test placed:  
  
MM/DD/YYYY 
Date skin test read:  
  
MM/DD/YYYY 
Two tuberculosis (TB) tests were performed as part of the National Health and Nutrition Examination 
Survey: a skin test and a blood test. Results below are for the skin test.  
The results from your blood test will be provided in the Final Report of Findings sent by mail 12–16 
weeks after the examination. If the blood test for TB infection is positive, we will notify you right away. 
 
 Positive 
Based on the skin readings, your child’s test for TB was positive (_____mm). This means that it is 
possible your child was infected with tuberculosis at some time in his/her life. Most people infected with 
tuberculosis never develop active TB disease. People who are infected but do not have active disease 
cannot spread tuberculosis to anyone else. If no one has told you before that your child may have been 
infected with TB, we strongly recommend you take this report to your child’s doctor or local health 
department as soon as you can. Your doctor or the health department may want to do another skin test and 
an examination to see if your child needs medicine to prevent active TB disease. The address and contact 
phone number for further evaluation at your local health department is provided separately. 
 
If you have any questions, you may call Dr. Kathryn Porter on one of our toll-free numbers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
English: 1-800-452-6115, press “2” Chinese: 1-866-887-7996, press “1” 
Spanish: 1-800-452-6115, press “3” Korean: 1-866-887-7996, press “2” 
   Vietnamese: 1-866-887-7996, press “3” 
The NHANES survey is a research study. Because no risk factor information was available at the time of 
the reading, a result of 10 mm or more of induration was considered positive. 
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Exhibit 4-14. Home Visit Tuberculosis Test Report of Findings – Adult: test is negative – Spanish 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT NEGATIVE 
Nombre del participante:   Número de la muestra:   
Fecha en la cual se tomó la prueba en la piel:  
  
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
  
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de Salud y Nutrición, se hicieron dos pruebas de 
tuberculosis: una prueba en la piel y una prueba de sangre. Los resultados a continuación son de la prueba 
en la piel. 
Los resultados de su prueba de sangre se proporcionarán en el Informe Final de Resultados que se envía 
por correo entre 12 y 16 semanas después del examen. Si el resultado de la prueba de sangre para la 
tuberculosis es positivo, le notificaremos inmediatamente.  
 
 Negativo  
Basado en las lecturas de la prueba en la piel, el resultado de su prueba de tuberculosis fue negativo 
(_____mm). Esto significa que usted probablemente no ha estado infectado(a) con tuberculosis.  
 
Si desea hacer alguna pregunta, puede llamar gratis a la doctora Kathryn Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las 8:30 de la mañana y las 6:00 de la tarde, hora del 
Este. 
Inglés: 1-800-452-6115, oprima “2” Chino: 1-866-887-7996, oprima “1” 
Español: 1-800-452-6115, oprima “3” Coreano: 1-866-887-7996, oprima “2” 
 Vietnamita: 1-866-887-7996, oprima “3” 
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Exhibit 4-15. Home Visit Tuberculosis Test Report of Findings – Adult: test is positive – Spanish 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT POSITIVE 
Nombre del participante:   Número de la muestra:   
Fecha en la cual se tomó la prueba en la piel:  
  
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
  
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de Salud y Nutrición, se hicieron dos pruebas de 
tuberculosis: una prueba en la piel y una prueba de sangre. Los resultados a continuación son de la prueba 
en la piel. 
Los resultados de su prueba de sangre se proporcionarán en el Informe Final de Resultados que se envía 
por correo entre 12 y 16 semanas después del examen. Si el resultado de la prueba de sangre para la 
tuberculosis es positivo, le notificaremos inmediatamente.  
 
 Positivo 
Basado en las lecturas de la prueba en la piel, el resultado de su prueba de tuberculosis fue positivo 
(_____mm). Esto significa que es posible que usted estuvo infectado(a) con tuberculosis en algún 
momento de su vida. La mayoría de las personas infectadas con tuberculosis nunca presentan la 
enfermedad activa de tuberculosis. Las personas que están infectadas, pero no tienen la enfermedad 
activa, no pueden contagiar a nadie con tuberculosis. Si nadie le ha dicho antes que usted puede estar 
infectado(a) con tuberculosis, le recomendamos enfáticamente que le lleve este informe a su médico o al 
Departamento de Salud local tan pronto como pueda. Es posible que su médico o el Departamento de 
Salud le quieran hacer otra prueba para ver si usted necesita medicinas para prevenir la enfermedad activa 
de tuberculosis. La dirección y número de teléfono para evaluación adicional en su Departamento de 
Salud local se proporcionan por separado. 
 
Si desea hacer alguna pregunta, puede llamar gratis a la doctora Kathryn Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las 8:30 de la mañana y las 6:00 de la tarde, hora del 
Este. 
Inglés: 1-800-452-6115, oprima “2” Chino: 1-866-887-7996, oprima “1” 
Español: 1-800-452-6115, oprima “3” Coreano: 1-866-887-7996, oprima “2” 
 Vietnamita: 1-866-887-7996, oprima “3” 
La encuesta NHANES es un estudio de investigación. Dado que no había información disponible sobre el 
factor de riesgo al momento de determinar el resultado, un resultado de 10 mm o más de endurecimiento 
se consideró positivo. 
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Exhibit 4-16. Home Visit Tuberculosis Test Report of Findings – Child: test is negative – Spanish 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – CHILD NEGATIVE 
Nombre del participante:   Número de la muestra:   
Fecha en la cual se tomó la prueba en la piel:  
  
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
   
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de Salud y Nutrición, se hicieron dos pruebas de 
tuberculosis: una prueba en la piel y una prueba de sangre. A continuación están los resultados de la 
prueba en la piel.  
Los resultados de la prueba de sangre de su niño(a) se proporcionarán en el Informe Final de Resultados 
que se envía por correo entre 12 y16 semanas después del examen. Si el resultado de la prueba de sangre 
de tuberculosis de su niño(a) es positivo, le notificaremos inmediatamente. 
 
 Negativo 
Basado en las lecturas de la prueba en la piel, el resultado de la prueba de tuberculosis de su niño(a) fue 
negativo (_____mm). Esto significa que su niño(a) probablemente no ha estado infectado con 
tuberculosis. 
 
Si desea hacer alguna pregunta, puede llamar gratis a la doctora Kathryn Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las 8:30 de la mañana y las 6:00 de la tarde, hora 
del Este.  
Inglés: 1-800-452-6115, oprima “2” Chino: 1-866-887-7996, oprima “1” 
Español: 1-800-452-6115, oprima “3” Coreano: 1-866-887-7996, oprima “2” 
 Vietnamita: 1-866-887-7996, oprima “3” 
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Exhibit 4-17. Home Visit Tuberculosis Test Report of Findings – Child: test is positive – Spanish 
HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – CHILD POSITIVE 
Nombre del participante:   Número de la muestra:   
Fecha en la cual se tomó la prueba en la piel:  
  
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
   
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de Salud y Nutrición, se hicieron dos pruebas de 
tuberculosis: una prueba en la piel y una prueba de sangre. A continuación están los resultados de la 
prueba en la piel.  
Los resultados de la prueba de sangre de su niño(a) se proporcionarán en el Informe Final de Resultados 
que se envía por correo entre 12 y16 semanas después del examen. Si el resultado de la prueba de sangre 
de tuberculosis de su niño(a) es positivo, le notificaremos inmediatamente. 
 
 Positivo 
Basado en las lecturas de la prueba en la piel, el resultado de la prueba de tuberculosis de su niño(a) fue 
positivo (_____mm). Esto significa que es posible que su niño(a) estuvo infectado(a) con tuberculosis en 
algún momento de su vida. La mayoría de las personas infectadas con tuberculosis nunca presentan la 
enfermedad activa de tuberculosis. Las personas que están infectadas, pero no tienen la enfermedad 
activa, no pueden contagiar a nadie con tuberculosis. Le recomendamos enfáticamente que le lleve este 
informe al médico de su niño(a) o al Departamento de Salud local tan pronto como pueda. Es posible que 
el médico de su niño(a) o el Departamento de Salud quieran hacer un examen para ver si su niño(a) 
necesita medicinas para prevenir la enfermedad activa de tuberculosis. La dirección y número de teléfono 
para evaluación adicional en su Departamento de Salud local se proporcionan por separado. 
 
Si desea hacer alguna pregunta, puede llamar gratis a la doctora Kathryn Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las 8:30 de la mañana y las 6:00 de la tarde, hora 
del Este.  
Inglés: 1-800-452-6115, oprima “2” Chino: 1-866-887-7996, oprima “1” 
Español: 1-800-452-6115, oprima “3” Coreano: 1-866-887-7996, oprima “2” 
 Vietnamita: 1-866-887-7996, oprima “3” 
La encuesta NHANES es un estudio de investigación. Dado que no había información disponible sobre el 
factor de riesgo al momento de determinar el resultado, un resultado de 10 mm o más de endurecimiento 
se consideró positivo. 
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4.7 Remuneration 
Pay a base remuneration of $40.00 for SPs who return to the field office or the staff hotel 
(after the stand closes) within the 46- to 76-hour window to have the test measurement taken. If the TB 
reader travels to the SP to take the measurement, or if test measurement is taken someplace other than the 
field office or the staff hotel, then pay the SP $15.00. 
 Transportation 
Examinees either provide their own transportation or take a cab provided by the survey staff. 
SPs are encouraged to provide their own transportation, if possible, and they will receive an additional 
transportation incentive if they do. The transportation incentive amount is calculated based on the stand 
and segment in which the SP lives and the amounts are predetermined by the field office staff. The 
segment transportation incentive amounts are determined at the start of each stand and will be provided to 
the TB readers when they arrive at the stand. 
One payment is made for all SPs from a household who travel together to the field office or 
hotel. If a SP from the household comes to the appointment at a different time or at the same time but in a 
different vehicle, then an additional allowance can be paid. 
For transportation by taxi, the field office attempts to arrange a voucher system to pay for 
cab fare. Under this arrangement, the taxi company provides vouchers that the TB Reader can use for the 
cab drivers when they drop off or pick up SPs. The field office or the taxi company provides the required 
number of vouchers on a daily basis, depending on the arrangement with the local taxi company. Less 
frequently, the taxi company requires a cash payment for transporting examinees. The TB reader must 
obtain a manual receipt from the taxi driver each time a cash payment is made for a fare. Ask the taxi to 
wait for the SP since the reading will usually take less than 15 minutes (longer if induration is present, or 
if supervised or blinded readings are being performed). 
4-40 
 Child Care/Adult Care 
Reimburse SPs who must hire a sitter to care for children, elderly, or handicapped persons in 
order to keep their TB skin test appointment. In addition, if a person is frail, ill, or handicapped and 
therefore needs help getting to the appointment, this “helper” can be paid. Pay for these services only if 
they are provided by a person not related to the SP. The fee for this service is $5.25 an hour. Reimburse 
for the number of hours required. 
For completed readings, complete a TB Receipt Calculation and Signature Form as the 
receipt (Exhibit 4-18.)  
Exhibit 4-18. TB Receipt Calculation and Signature Form 
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Ask the SP to sign the receipt indicating that he or she has received the cash payment. If the 
SP is between the ages of 6 and 17, the parent or adult accompanying the child to the field office signs the 
receipt. If an unaccompanied child age 12-17 arrives at the field office, the child can sign the receipt but 
another field office staff member also signs as a witness. 
4.7.1 Petty Cash 
The office manager (OM) provides the TB readers with the amount of cash required for the 
day’s scheduled appointments and additional funds for unscheduled readings and readings performed in 
SP’s homes. The TB readers reconcile the petty cash account with the OM weekly or when requested by 
the OM. The cash remaining in the TB petty cash fund, plus the value of the signed receipts, must equal 
the amount of cash advanced by the OM. 
4.8 Reports in the FFMS 
4.8.1 Report of SPs with Scheduled Appointments – NOT YET AVAILABLE 
The report of SPs with scheduled appointments allows the TB readers to view all currently 
scheduled TB appointments. The report lists the SP’s name, SP ID, address, telephone number, date, time 
that the antigen was administered, and a time range for reading the TB skin test result. The report also 
includes any comments entered by the MEC examination staff indicating where the SP requested that the 
TB skin tests be read (FO or home). Filters built into the report system allow the TB readers to select a 
range of dates and reading locations. The TB readers use the Report of SPs with Scheduled Appointments 
when making reminder telephone calls and as a schedule of the day’s appointments. 
4.8.2 Report of SPs without Scheduled Appointments – NOT YET AVAILABLE 
This report lists all SPs who had the antigen administered but for whom no reading 
appointment exists. The report lists the SP’s name, SP ID, address, telephone number, date and time 
antigens were administered, and a time range for reading the TB skin test results. The report also indicates 
the type of transportation arrangements made for the MEC appointment (self or taxi), and includes any 
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comments entered by the MEC examination staff indicating where the SP requested that the TB skin tests 
be read (FO or home). 
4.9 Refusal Conversion Phone Calls 
If a SP does not show up for field office scheduled appointment, attempt to reschedule the 
TB reading. TB skin test reading must occur between 46 and 76 hours after placement of the TST. The 
TB readers attempt to reschedule missed appointments for the earliest available appointment slot 
acceptable to the SP in the SP’s home, but the reading must occur no later than 76 hours after 
administration of the antigen. The reader should prioritize missed appointments and attempt first to 
reschedule those SPs with the shortest time period left before the 76-hour cutoff ends. If the SP is offered 
a TB reading in the home and refuses, attempt an unannounced home visit if time permits before finally 
coding the reading as “Refused.” 
4.9.1 Nonresponse Follow-up of SPs Who Miss a Scheduled TB Reading 
TB readers conduct unannounced home visits as time permits. These visits are primarily 
designed to increase the response rate for this component. Attempt to make one unannounced home visit 
for each SP who fails to show for a scheduled appointment; however, conduct home readings less than 75 
hours after placement of the TST. Prioritize unannounced home visits so that visits are made first to SPs 
with the shortest time left before the 76-hour cutoff ends. If a home visit is attempted and no one is 
contacted, leave a reminder card at the home requesting that the SP call the field office to reschedule the 
appointment. Use the TB Skin Test Home Reminder Card for this purpose. Refer to Exhibit 4-19 and 4-20 
for an illustration of the Home Visit Reminder Card in English and Spanish. This card is printed with 
English on one side and Spanish on the other. 
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Exhibit 4-19. Home Visit Reminder Card - English 
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Exhibit 4-20. Home Visit Reminder Card – Spanish 
4.10 Reading TST Results after the Stand Closes 
MEC examination staff place TB skin test antigen through the last MEC exam day at all 
stands. TB readers remain at each stand up to 3 days after the last examination session to measure skin 
reactions. The field office is not available during this period; therefore the measurement of tests placed on 
the last 2 to 3 days of the stand are read either in a designated room at the staff hotel or in the SP’s home. 
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4.10.1 End of Stand Procedures 
In most stands the field office closes immediately following the last MEC examination 
session. Confirm this date with the office manager. Complete the following tasks after the last MEC 
examination session: 
1. Work with the home office supervisor to review appointments and work schedules. 
2. Generate and review reports of reading appointments and SPs who received the skin 
test antigens but do not have scheduled appointments. 
3. Obtain enough cash from the office manager (OM) for all scheduled and not 
scheduled appointments and transportation remuneration. The OM also provides a 
petty cash reconciliation form that is completed before the readers leave the stand. 
4. Conduct an end of stand inventory. 
5. Complete all TST readings. 
6. Reconcile petty cash and obtain a cashier check for all remaining cash. 
7. Send the cashier check and copies of documents, including printed reports, and the 
receipt book, to the home office supervisor. 
Verify that each reader has sufficient supplies to complete all readings, including copies of 
ROF forms. 
4.10.2 Measurement of Skin Reaction after the Field Office Closes 
Once the field office closes, readers make reminder telephone calls from their hotel rooms 
and measure skin test reactions in SP homes and the designated room in the hotel. It is anticipated that the 
number of readings scheduled during this period will be relatively small. The TB readers should 
accompany each other whenever possible when conducting these end of stand readings, and should 
conduct BIDRs when possible. 
The home office supervisor provides the readers with the date and time they may leave the 
stand to travel to the next stand. If all work is completed before this time, the TB readers may leave the 
stand after notifying their home office supervisor. 
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4.10.3 Tasks Completed before Leaving a Stand 
Before leaving a stand, the TB readers complete all readings and then contact the home 
office supervisor to notify him or her that TB readings at the stand have been completed. Do not leave any 
paperwork with confidential information at the stand. Send it to the home office so it can be shredded. 
Return the following items in a FedEx box to the home office supervisor before leaving the 
stand: 
1. Money order for any unspent remuneration funds. Attach the money order to the petty 
cash reconciliation form. Copies of any signed receipts are also attached to the form. 
The value of the money order added to the value of the signed receipts should equal 
the petty cash advanced to the TB readers; 
2. The inventory sheet and copies of all other paperwork.; and 
3. TB rulers. 




4. Zippered money bag 
5. Portable reader head lamp 
6. TB reader cosmetic bag and supplies 
4.11 Written Data Forms 
In the event that the TB Reading application is unavailable, use the TB Reading Form 
(Exhibit 4-21) to document the results and enter the information into the application as soon as it’s 
available. Attempt to conduct BIDRs whenever possible. Complete a form for each type of reading and 
take care to note if it is the initial reading or a QC reading. 
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Exhibit 4-21. TB Reading Form 
TB READING FORM 
SP ID:   Name:   
Last name, first name, middle name 
Age:   Gender:   
Date of Application:   
MM/DD/YYYY 
Time of Application:   
XX hours XX minutes 
Application Location:   
Left arm or Right arm 
  
Current Date:   
MM-DD-YYYY 
Current Time: __________________________ 
HH:MM AM/PM 
Is the number of hours since placement less than 76? Yes  
 No  
  
Technician Name:   
Initial Reading   
QC Reading  
Induration:   
Whole number between 0 and 86 
87+ mm   
Refused   
Could Not Obtain  
Vesiculation or Bullae: 
Present   
Absent   
Could Not Obtain   
Ulceration or Necrosis: 
Present   
Absent   
Could Not Obtain   
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4.12 Entering Results in ISIS 
ISIS provides data entry screens for entering the measurement of the skin test. Open the 
application, log on, and enter all results using the text boxes and drop-down lists on the screens. Once the 
Report of Findings (ROF) is displayed on the screen click print to actually print it. If the printer is not 
connected for some reason, for example a home reading, then transfer the data displayed on the screen to 
the appropriate Home Visit Tuberculosis Test Report of Findings form. 
4.12.1 Begin the Exam and Logon 
Open the TB Reader application. The application appears as an icon on the desktop. 
To open or access the TB Reader application, double click on the icon. 
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Log onto the TB Reader application. 
Type last name_first initial in the User ID: text box, [TAB], and then type the password in 
the Password: text box. Click the OK button to proceed. To exit, click the Cancel button. To change the 
password, click the Change Password button. 
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4.12.2 Record TB Readings 
The TB Reader exam screen displays. 
To access a list of SPs, click the left most button on the button bar. 
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The TB Reader SP Pickup window displays. 
The TB Reader SP Pickup window includes the Household ID, SP ID, Name, Age, 
Language, and Time Since Placement. The “Show all appointments” checkbox defaults to unchecked. 
When this box is unchecked it only shows SPs who are within the 46-76 hour reading window. Checking 
the box will display all SPs with antigens placed but not yet read. 
To select a specific SP, use the mouse to click on an SP or use the up and down arrows to 
highlight a row and click the OK button. To exit the window, click the Cancel button. 
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The TB Skin Testing – Reader’s Screen displays for all SPs whose time since placement is 
between 46 and 76 hours. 
If the time since placement is outside the reading window an informational box displays. 
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The TB Skin Testing – Reader’s screen includes all the necessary information to complete 
the reading. 
 SP ID, Name (last, first), Age, Gender, Current Date and Current Time 
 Date of Application 
 Time of Application (xx:xx AM or PM) 
 # Hrs Since Placement (The number of hours and minutes since the antigens were 
placed) 
 Placement Location: (Left Arm or Right Arm) 
 Reading location (Field Office, SP’s Home, Other) 
 Induration (measurement in millimeters) 
 Vesiculation or Bullae (Present, Absent, Could not Obtain) 
 Ulceration or Necrosis (Present, Absent, Could not Obtain) 
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 Reading conducted on Hard Copy (No, Yes) 
 Reading conducted on (MM/DD/YY hh:mm) 
 QC - No button (No, Yes) 
The number of hours since the antigen application must be between 46 hours 0 minutes and 
76 hours 0 minutes to be valid. If the elapsed time is less than 46 hours, ask the SP to return when the 46-
hour minimum requirement is met. If the elapsed time is greater than 76 hours, inform the SP that the skin 
reaction cannot be measured. If the SP is interested in receiving test findings, refer them to the local 
health department or their regular source of medical care for another TB skin test. 
Verify the date and time of application and the number of hours since placement. Use the 
Placement Location to identify the correct arm. Select the reading location. 
Select the reading location by clicking on the drop-down list and choosing Field Office, SP’s 
Home, or Other.   
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If the application is not available, complete the reading on hard copy. Document if the 
reading was conducted on hard copy. 
The field defaults to “No.” To change the answer from “No” to “Yes,” select “Yes” from the 
drop-down list. 
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The “Reading conducted on” text box is editable if the value of “Reading conducted on hard 
copy” is “Yes.” Use the calendar to correct the date and key enter the time to reflect the actual date and 
time of the reading written on the hard-copy form. 
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Enter the measurement of the diameter of the induration in millimeters in the “Induration” 
data entry field. Enter the induration measurement using the keyboard numeric keys. Select [Tab] to move 
to the vesiculation or bullae text box. 
Either enter a numeric value between 0 and 86 or select one of the three options from the 
drop-down list. If the measurement is 87 millimeters or greater, select “87+ mm” from the drop-down 
menu. 
If the SP refuses to allow measurement of the skin reaction, select “Refused” from the drop-
down menu. If the measurement could not be obtained for any reason other than SP refusal, select “Could 
not obtain” from the drop-down menu. If selecting either the “Refused” or “Could not obtain” option, 
indicate the exact reason using the “comments” field on the final TB Skin Testing Status screen. 
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Only a value between 0-86 is permitted. 
An Invalid number window displays if a value greater than 86 is entered in the Induration 
field. To remove the window, click on the OK button. 
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 Vesiculation or Bullae  
Vesiculation and bullae are fluid-filled, blister-like lesions in the area of the TB antigen 
injection site. Indicate the presence or absence of vesiculation and/or bullae. 
To record either “Present,” or “Absent,” or “Could not obtain, select one of the three choices 
from the drop-down list. Indicate the presence or absence of vesiculation and/or bullae by selecting 
“Present” or “Absent” from the drop-down menu. 
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If the reader selects “Present,” a pop-up confirmation box appears with the statement, 
“Please confirm that the vesiculation/bullae are indeed present.” 
If either vesiculation or bullae are present, complete an Adverse Reaction Form. 
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 Ulceration or Necrosis  
Ulceration and necrosis are terms that describe skin damage, usually raw, open sores. 
To record either “Present,” or “Absent,” or “Could not obtain,” select one of the three 
choices from the drop-down list. Indicate the presence or absence of ulceration and/or necrosis by 
selecting “Present” or “Absent” from the drop-down menu. 
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If the reader selects “Present,” a pop-up confirmation box appears with the statement, 
“Please confirm that the ulceration/necrosis are indeed present.” 
If either ulceration or necrosis is present, complete the Adverse Reaction Form. 
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If quality control measurement of skin reactions is not going to be completed on the SP, 
progress to the next screen. The TB Skin Testing Status screen displays. 
To progress to the section status screen, click the bright blue arrow in the bottom right hand 
corner. 
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If the blue arrow is selected before all text boxes have data, a warning window displays. 
The warning box indicates that all items have not been answered. To remove the warning 
box, click the OK button. 
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4.12.3  QC Readings 
The TB Reader’s QC screen is very similar to the Reader’s screen used for recording the 
initial measurement of the skin reaction. Record all skin test measurements. All subsequent readers do not 
see the measurement obtained by any previous reader. After the final set of readings is completed, 
selecting the “next screen” arrow brings up the TB component status screen. 
If a second TB reader is available and if the SP is willing to undergo a second set of 
measurements for quality control purposes, click the “QC-NO” button to allow another reader to record 
their readings. When this button is clicked, the “No” changes to “Yes.” 
When the “next screen” bright blue arrow is clicked the TB Reader’s QC screen displays. 
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The TB Skin Test – Reader’s Screen QC Reading 1 displays. Select the Technician (Reader 
Name) ID from the drop-down list. Complete all readings and enter results. The TB Skin Test – Reader’s 
Screen QC Reading 1 does not include the Reading conducted on hard copy and Reading conducted on 
text boxes. It is assumed if the initial reading is done on laptop then the QC reading is done on the laptop 
and likewise if the initial reading is done on hard copy then the QC reading is done on hard copy. So, 
basically the entry on the first screen applies to both the initial entry and all related QC readings for the 
SP. 
If there are no further readings, the second reader should select “No” to the QC question. If 
another reader is to perform a BIDR, the second reader should select “Yes.” Enter up to eight QC 
readings by clicking the “QC” button at the bottom of the TB Reader’s QC Screen. The “No” will change 
to “Yes” on this screen as it did on the previous screen when this button was clicked. When the “next 
screen” arrow is selected another QC Screen is displayed. The report of findings prints after all readings 
are complete.  
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4.12.4  TB Skin Testing Section Status 
ISIS assigns the component status for measurement of the skin reaction based on the 
following criteria: 
 Complete - a numeric value entered in the induration field or 87+ selected from the 
drop-down. 
 Not done - induration numeric field is left blank and “Could not obtain” or “Refused” 
is selected in the related drop-down list. 
Review the TB Skin Testing – Status screen. 
Enter a required comment if the component status is “Not Done.” 
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Choose and enter the appropriate comment code when the TB Skin Testing status is not 
done. 
To record a comment in the Comments text box, select the desired code from the drop-down 
list. 
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Comment Code Use when: 
communication 
problem 
SP is unable to understand and follow instructions for the component due to 
language, cognitive impairment, or other problem, and is unable to complete 
the test. 
equipment failure Not applicable 
interrupted The exam is interrupted, usually for a field office-wide emergency, and cannot 
be completed by the SP. 
Language Barrier SP is unable to understand and follow the instructions for the component due 
to language and interpreting difficulties, and is unable to complete the test. 
no time Not applicable 
other, specify If the above reason for a status Code of Not Done is not explained by one of 
the Comment Codes, the examiner must choose Other, text and record a 
comment in the text field. 
physical limitation SP is unable to have the test due to a physical problem. 
Reading not done 
within 76 hours 
The TB skin test reading was not completed within the 76 hour time limit. 
safety exclusion Not applicable 
SP ill/emergency The SP became ill or an emergency occurred and the test could not be 
performed on the SP. 
SP refusal The SP refuses to have the skin test read. This is SP initiated nonresponse due 
to refusal. The SP refuses the component or a part of the component for any 
reason other than an illness or emergency.  
When finished, click the Finish button at the bottom, center of the screen. 
The Report of Findings will be displayed and if a printer is connected, the ROF should be 
printed for the SP. 
4.12.5 Reprinting Report of Findings 
Reprint ad-hoc Report of Findings for individual SPs either in English or Spanish. 
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To reprint an ROF select the Report of Findings option under the Reports menu. 
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The TB Reader SP Pickup window displays. 
Select the SP from the list by highlighting the row and click OK to continue. To exit click 
the Cancel button. 
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5. FIELD FOLLOW-UP MANAGEMENT SYSTEM (FFMS) 
Use the Field Follow-up Management System (FFMS) to manage all TB reading 
appointments. Use this system to view, schedule, and reschedule appointments, and to record call results 
on a daily basis.  
From a TB perspective, the FFMS has one main purpose and that is to manage the contacts 
and appointments for TB readings, although the FFMS is used by many different people on the NHANES 
study and serves many different purposes. It has been modified for the TB, readers, but was not 
specifically designed for TB, and for this reason it may display some fields that will not be used by the 
TB readers. All FFMS procedures that are needed to manage appointments are covered in this chapter. 
The actual data collected during the reading process will be recorded using the TB Reader application on 
the laptop.  
As mentioned in the previous chapter, an appointment for an SP’s TB reading will normally 
be scheduled by the MEC staff member after the placement of TB antigen during the SP’s MEC exam. In 
general, MEC staff personnel performing the TB placement make the appointment for the TB reading 48-
52 hours after the TB antigens are placed. However, if circumstances require, the appointment can and 
will be made between 46-76 hours after placement. Each TB reader will have a specific work schedule 
(days and hours) and will be assigned specific SPs to be read. The TB reader work schedule, and 




Once an appointment has been scheduled, it is the TB Reader’s responsibility to contact the 
SP again a day or two before the appointment. During this call: 
Follow the TB reading reminder call talking points. 
If the SP needs to reschedule, then schedule the reading for a time that is most 
convenient for the SP within 46-76 hours from placement, but as close to the 48-52 
hour ideal window as possible. 
In addition to conducting reminder calls for previously scheduled appointments, TB Readers 
are responsible for scheduling appointments for SPs who were not scheduled at the time their TB antigen 
was placed. Procedures for scheduling these appointments are covered later in this chapter.  
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Finally, during the course of the workday, record each attempt to contact an SP in the FFMS. 
If preferred, all contact attempts may be written on the TB Reminder Calls report but if this is done all of 
these contact results must be entered into the FFMS at the end of the workday. Reminder: The TB 
Reminder Calls report and all other hard-copy documents containing confidential SP data must be 
locked in a desk or file cabinet when not in use and these documents must be shredded when no 
longer needed. 
5.1 Logging onto the FFMS 
1. Double click on the FFMS 
Icon on your desktop to open 
the FFMS logon screen. 
2. Enter user ID as last name_ 
first initial. 
3. Enter password. 
4. Click on the blue login button. 
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5.2 Summary of FFMS Functions 
Contact Manager – Use this 
header to search for current 
phone and address 
information. 
Appointment Manager – Use 
this header to view 
appointments by Day, Week, or 
Month, and to access the New 
Appt., Reschedule, Appt. 
Monitor, and Not Sched. tabs. 
Reminder Calls – Use this 
header to display 
information needed to make 
reminder calls for upcoming 
appointments. 
Call History – Use this 
header to search for the call 
history for an SP, enter result 
codes, and can also be used 
to reschedule an 
appointment. 
Reports – Will not 
be used by the TB 
Readers at this time. 
The quickest and easiest way to see an overview of scheduled appointments is by using the 
day, week, or month tabs under the Appointment Manager link. These tabs display a calendar view of the 
appointments for a given day, week, or month. Note that for TB reading, the month tab will not be very 
useful, since TB readings must be completed within 76 hours of placement. 
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5.3 Viewing Appointments Using the Day Tab 
Use the day tab to view all of the appointments for a given day. The day tab shows the 
appointment times, the SP’s name, appointment status, and the name of the TB Reader with whom the 
appointment is scheduled.  
1. Click on the Appointment 
Manager header at the top of 
the screen. 
2. Click on the “Day” tab. 
3. Select the appropriate month 
by clicking on the < or > 
symbol on either side of the 
current month on the calendar. 
4. Select the day to view 
appointments by clicking on 
the date within the calendar. 
5. The appointments for that date 
appear to the right of the 
calendar. 
6. Clicking on an SP’s underlined 
name will display the call 
history. If needed, enter a call 
record or reschedule the 
appointment. 
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5.4 Viewing Appointments Using the Week Tab 
Use the week tab to view all appointments for a given week. Only the appointment times and 
the name of the SPs appointed to that time slot display.  
1. Click on the Appointment 
Manager header at the top of 
the screen. 
2. Click on the “Week” tab. 
3. Select the appropriate month 
by clicking on the < or > 
symbol on either side of the 
current week on the calendar. 
4. Select the specific week to 
view appointments by clicking 
on the > next to the 
appropriate week. 
5. The appointments for that 
week will display to the right 
of the calendar. 
6. Clicking on an SP’s underlined 
name will display the Call 
History. If needed, enter a call 
record or reschedule the 
appointment. 
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5.5 Viewing Appointments Using the Month Tab 
Use the month tab to view all of the appointments for a given month. Note that for TB 
reading, the month tab will not be all that useful, since TB readings must be completed within 76 hours of 
placement.  
The names will appear in different colors indicating the appointment status. Green = 
scheduled, firm appointment; Black = scheduled, tentative appointment; Red = not scheduled, broken 
appointment; Blue = appointment completed; Brown = appointment final nonresponse.  
1. Click on the Appointment 
Manager header at the top of 
the screen. 
2. Click on the “Month” tab. 
3. Due to the size of this screen, 
use the scroll bar to view the 
entire calendar. 
4. Select the appropriate month 
by clicking on the < or > 
symbol on either side of the 
current month on the calendar. 
5. A full calendar displays all of 
the appointments. They are 
color coded by appointment 
status (see the key at the 
bottom of the screen). 
6. Clicking on an SP’s underlined 
name will display the Call 
History. If needed, enter a call 
record or reschedule the 
appointment. 
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5.6 Viewing and Printing the Appointment Schedule 
Use the Appointment Monitoring Report tool to view the upcoming appointments. Also use 
this report to view your broken appointments. 











Participant No – Stand ID, Segment #, Serial #, Family #, and Person #. – Note that 
SPs with the same Stand ID, Segment #, and Serial # live in the same household, Age,  
MEC exam date,  
Appointment date and time,  
Assigned TB Reader,  
Number of hours since placement, and  
Address – the home address of the SP to be used if the SP prefers to have their reading 
completed at home. 
The report can be filtered by appointment status, allowing the option to view only those SPs 










Interviewer (TB Reader), 
Appointment Date/Time, or 
Hours Since Placement. 
The report can be printed as it appears on the screen.  
1. Click on the Appointment 
Manager header at the top of 
the screen. 
2. Click on the “Appt. Monitor” 
tab. 
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3. Make sure that the correct 
stand is highlighted. 
4. Select the desired appointment 
status. 
5. Click the “Filter” button. 
6. Sort the report as desired using 
the “Sort by” drop-down list. 
7. Print the report using the File, 
Print menu option. 
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5.7 Scheduling Appointments for “Not Scheduled” SPs 
While most of your SPs will be appointed by the MEC staff that places the SP’s antigen, 
some will not. This can happen for a variety of reasons, such as when the SP does not know their 
availability at the time of placement, or is willing to be placed but refuses to come to the field office for 
their reading. Regardless of the reason, these cases will appear on the list of not scheduled cases located 
on the “Not Sched.” tab. For these cases, it will be the TB Reader’s responsibility to schedule the reading 
appointment.  
1. Click on the Appointment 
Manager button at the top of the 
screen. 
2. Access the list of “not 
scheduled” appointments by 
clicking on the Not Sched. tab. 
3. Contact the SP to schedule an 
appointment. 
4. Click on the blue underlined 
SP ID to schedule an 
appointment.  
5. Click on a calendar date to 
display appointment times 
available on that date. 
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6. Scroll the screen to display all 
available appointments on the 
selected date. 
7. If needed, use the Language 
drop-down list to display 
appointments for readers who 
speak the SP’s preferred 
language. 
8. Check the “Schedule” box 
beside the desired appointment 
to schedule a reading in the 
field office. 
OR  
Check “Schedule for Home” 
for the desired appointment to 
schedule a reading at the SP’s 
home. 
9. If you are ready to schedule 
the appointment, scroll back 
up and click on the Schedule 
Appointment button.  
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5.8 Rescheduling Appointments for SPs Already on the Schedule 
There may be times when an SP needs to reschedule their TB reading appointment. Use one 
of the two methods described below to find the SP’s existing appointment and to reschedule them to a 
new appointment date and time.   
Remember to reschedule the reading for a time that is most convenient for the SP within 46-
76 hours from placement but as close to the 48-52 hour ideal window as possible. Pay close attention to 
the expiration date and time displayed on the call history window to ensure that the convenient 
appointment is as close to the ideal window as possible. 
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OPTION #1 – Use this option if the SP’s current appointment date is known. 
1. View the appointment you 
wish to reschedule on the Day, 
Week, or Month tab, or search 
for the SP under Call History. 
2. Click on the underlined name 
of the SP. 
3. Click “Yes,” contact made 
with SP. 
4. Click “Yes,” reschedule 
appointment. 
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5. Click on a calendar date to 
display appointment times 
available on that date. 
6. Scroll the screen to display all 
available appointments for the 
selected date. 
7. If needed, use the Language 
drop-down list to display 
appointments for readers who 
speak the SPs’s preferred 
language. 
8. Check the “Schedule” box 
beside the desired appointment 
to schedule a reading in the 
field office. 
OR  
Check “Schedule for Home” 
for the desired appointment to 
schedule a reading at the SP’s 
home. 
9. When ready to schedule the 
appointment, scroll back up 
and click on the Schedule 
Appointment button.  
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OPTION #2 - Use this option if the SP’s current appointment date is not known. 
1. Click on the Call History 
header at the top right of the 
screen. 
2. Enter the SP ID, last name or 
first name, or any combination 
of the three for the SP and 
click on Search. 
3. The FFMS will display all SPs 
who match the search criteria.  
4. To view the Call History, click 
the select button next to the 
appropriate SP.  
5. Follow steps 3 through 9 under 
option #1 to reschedule the 
appointment. 
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5.9 Call History 
Use the Call History to record the results of all contact attempts and to reschedule 
appointments. There are two ways to view and make entries on the Call History. The first and easiest way 
is to click on the underlined name of the SP while viewing appointments in the day, week, or month view. 
This option works only if the appointment has been scheduled. 
OPTION #1 
1. View the appointment you wish 
to reschedule on the Day, 
Week, or Month tab, or search 
for the SP under Call History. 
2. Click on the underlined name of 
the SP. 
3. Scroll down to view the Call 
History entries that have been 
made for the SP. 
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4. Answer the two Yes or No 
questions appropriately. If the 
answer to the second question 
is “Yes,” the system 
automatically proceeds to 
reschedule the appointment. 
5. If the answer to the second 
question is “No,” select a 
result code from the drop-
down menu. Click on the 
down arrow and select the 
appropriate code. 
6. If a result code of other was 
selected, type a reason into the 
text field provided. 
7. Click on the pink “Update call 
info” button. 
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The second way to view and make entries on the Call History is through the Call History 
button at the top right of the screen. Use this to search for a case using the SP ID, first name, or last name, 
of any SP in the family. 
OPTION #2 
1. Click on the Call History 
header at the top right of the 
screen. 
2. Enter the SP ID, last name or 
first name, or any combination 
of the three for the SP and 
click on Search. 
3. The FFMS will display all SPs 
who match the search criteria.  
4. To view the Call History, click 
the select button next to the 
appropriate SP. Be very 
careful to pick the correct SP.  
5. Follow steps 3 through 7 under 
option #1 to update the Call 
History. 
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5.10 Contact Manager – Viewing Addresses and Phone Numbers 
Use the Contact Manager to view the current phone number, street address, and mailing 
address for any SPs. Search by SP ID, last name, first name, or phone number, or a combination of any of 
the four. 
1. Click on the Contact Manager 
header. 
2. Enter the desired search 
criteria by typing in one or 
more of the boxes. 
3. Click the “Search” button. 
4. To view the contact 
information, select the 
appropriate SP. 
5-19 
5. SP phone and address 
information displays. 
6. Note, that the FFMS cannot be 
used to update phone and 
address information so contact 
the field office staff if updates 
are needed. 
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5.11 Making Reminder Calls  
Use the Reminder Calls window when making reminder telephone calls to display the list of 
SPs with scheduled appointments who have not yet confirmed their appointment. The report allows the 
TB reader to view all currently scheduled TB appointments which have not received a successfully 
completed reminder call. The report provides the ability to filter the list for appointments for today, the 
next day, next 2 days, and the next 3 days. Normally, the “Today” filter will not display any SPs since all 
reminder calls should be attempted and completed the day before the SP’s schedule appointment. 
The report lists the following information for each SP: SP ID, SP Name, Phone No., 
Language, Appt. Date, Appt. Status, # Hrs Since Placement, Interviewer (primary TB Reader), Stand, 
Age, Call Made, and Call Attempted. 
 
1. Use the “Call Made” checkbox 
to indicate that the reminder 
was successfully completed 
and the appointment was 
confirmed. 
2. Use the “Call Attempted” 
checkbox to indicate that the 
reminder was attempted 
several times but the SP could 
not be reached to confirm their 
appointment. Only check this 
box when no additional 
attempts will be made.  
When either “Call Made” or “Call Attempted” is checked the SP will be removed from this 
report, so only check these boxes when no additional attempts will be made to contact the SP. 
When making reminder calls: 
Check the “Call Made” checkbox to indicate that the reminder was successfully 






Check the “Call Attempted” checkbox to indicate that the reminder was attempted 
several times but the SP could not be reached. 
Record all contact attempts using the Call History functions outlined in Section 5.9; 
If needed, reschedule the SP’s appointment using the functions outlined in Section 
5.8; 
If needed, use the Contact Manager functions outined in Section 5.10 to obtain 
additional phones for SPs that cannot be reached. 
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2011-2012 TB Ruler Specifications 
Manufacturer 
Loomis Sales Corporation 
716 Maple Street 







• One thousand each of two types 
• Plastic 6” ruler (150mm x 37mm) 
• Clear 
• Flexible 
• Millimeter increments from zero to 90 
o 1000 rulers with 0, 10,  20, 30, 40, 50, 60, 70, 80, 90 (even markings) 
o 1000 rulers with 0,  5, 15,  25, 35, 45, 55, 65, 75, 85 (odd markings) 
• Zero mark 15mm from the left edge 
• Black ink 
• Engrave the words, “1. Inspect, 2. Palpate, 3. Mark, 4. Measure” on the bottom (4mm high) 
• Incrementally add a unique serial number to each ruler 
o Start with 0001 and 2011 
o Engrave in black on white on right edge 
Warehouse Quality Control Procedures 
• When the new rulers arrived in the warehouse, the staff compared all new rulers to the master 
ruler and put the new rulers into circulation if all markings matched.  (If any fail the calibration, 
notify NCHS and component staff.) 
• Routinely send 12 rulers at the start of each stand – four for each of the three TB techs. 
• Track each ruler by stand number and TB tech 
End of Stand Procedures 
• TB techs send all rulers back to the home office supervisor at the end of every stand and she or he 
returns them to the warehouse supervisor who will compare them to the master ruler and put them 
back into circulation. 
Rotating Rulers 
Warehouse - rotate the odd and even markings according to this schedule: 
Even   Odd 
278   279 
281   280 
282   283 
284   285 
286   287 
288   289 
290   291 and 292 
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Master Ruler Calibration and Certification 
Contact 
NIST 
ATTN: Chris Blackburn 
100 Bureau Dr. Mail Stop 8211 
Gaithersburg, MD 20899 
Large Scale Coordinate Metrology 
(301) 975-6413 
chris.blackburn@nist.gov 
Email letter that accompanied the master ruler: 
Mr. Blackburn, 
I am sending you a six-inch metal ruler and request that NIST calibrate it at the first 20 mm marks and 
seven additional points at the 30, 40, 50, 60, 70, 80 and 90 marks. 
I am enclosing a return air bill so you can ship the calibrated ruler to CJ Bittner in our warehouse in 
Gaithersburg. 
Brenda Lewis 
CDC/NCHS, Rm 4219 
3311 Toledo Road 
Hyattsville, MD 20782 
301-458-4343 
bgl1@cdc.gov
The price for tape calibrations is $499 for a 7-point calibration, plus $10 for each additional point (if any) 
that you would like calibrated. 
Send the master ruler or tape to the following address: 
NIST 
ATTN: Chris Blackburn 
100 Bureau Dr. Mail Stop 8211 
Gaithersburg, MD 20899 
Include a PO in the box with the tape, or fax it to (301) 975-5360, or send a pdf version to his email 
address. The PO should include a brief description of the tape (something like “100 foot Steel Tape” is 
fine) and a list of the points you would like calibrated. Alternatively, you can pay for the calibration with 
a credit card. Please contact him for more information about this option. 
Return shipping can be charged to your FedEx/UPS account number (please include this on the PO) or 
will be a flat fee of $30 added to the cost of the calibration. 
The turnaround time for tape calibrations is 4 weeks from the time the tape is received by NIST. 
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Picture of rulers 
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 Appendix B 
Hard-Copy Forms 
 Adverse Reaction Report 
 Data Entry – Reading Form 
 Receipt Calculation and Signature Form 
 Adult ROF-TB Neg – English 
 Adult ROF-TB Neg – Spanish 
 Adult ROF-TB Pos – English 
 Adult ROF-TB Pos – Spanish 
 Child ROF-TB Neg – English 
 Child ROF-TB Neg – Spanish 
 Child ROF-TB Pos – English 
 Child ROF-TB Pos – Spanish 
NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 
 
TUBERCULOSIS (TB) SKIN TESTING 
ADVERSE REACTION REPORT 
Sample Person (SP) Information 
SP ID:   ____________________________ 
 Insert participant sample number. 
TB Skin Test (TST) Information 
Date and Time of Administration: 
|__|__|-|__|__|-|__|__|__|__| |__|__| : |__|__| 
 MM DD YYYY HR MIN 
 AM 
 PM 
Date and Time of Reading: 
|__|__|-|__|__|-|__|__|__|__| |__|__| : |__|__| 




Arm: Vesiculation/Bullae: Ulceration/Necrosis: Antigen: 
 Right 
 Left 
Induration:        mm  Present  
 Absent 
 Present  
 Absent Tubersol 
Report of Findings 
Comments or descriptions of other adverse reactions: 
TST result:  Positive 
  Negative 
TST Reader 
Tech ID:  _______________________ 
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TB READING FORM 
SP ID:   Name:  
Last name, first name, middle name 
 
Age:   Gender:   
Date of Application:  
MM/DD/YYYY 
 Time of Application:  
XX hours XX minutes 
 
Application Location:  




Current Date:   
MM-DD-YYYY 
Current Time: __________________________ 
HH:MM AM/PM 
Is the number of hours since placement less than 76? Yes  
 No  
  
Technician Name:   
Initial Reading   
QC Reading  
Induration:   
Whole number between 0 and 86 
87+ mm   
Refused   
Could Not Obtain  
Vesiculation or Bullae: 
Present   
Absent   
Could Not Obtain   
Ulceration or Necrosis: 
Present   
Absent   






TB Receipt Calculation and Signature Form  
Print Name___________________________   
Date________________________________   
Segment Number______________________ 
Base Remuneration  
Transportation  
Adult/Child Care  
Total   
 
Signature_________________________  Amount Received $__________ 
TB Receipt Calculation and Signature Form  
Print Name___________________________   
Date________________________________   
Segment Number______________________ 
Base Remuneration  
Transportation  
Adult/Child Care  
Total   
 
Signature_________________________  Amount Received $__________ 
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HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT NEGATIVE 
Participant Name:   Sample Number:   








Two tuberculosis (TB) tests were performed as part of the Nationa l Health and Nutrition E xamination 
Survey: a skin test and a blood test.  Results below are for the skin test.   
The results from  y our blood test will be provide d i n the Final Report of Findings sent by  mail 12–16 





Based on the skin readings, y our test result for TB  infection was negative (____mm).  Thi s means that  




If y ou have any questions, y ou m ay call Dr. Kathr yn Porter on one of o ur toll-free num bers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
 
English: 1-800-452-6115, press “2” 
Spanish: 1-800-452-6115, press “3” 
Chinese: 1-866-887-7996, press “1” 
Korean: 1-866-887-7996, press “2” 





HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT NEGATIVE 
Nombre del participante:  Número de la muestra:  
Fecha en la cual se tomó la prueba en la piel:  
 
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
 
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de  Salud y Nutrición, se hicieron dos pruebas de  
tuberculosis: una prueba en la piel y una prueba de sangre. Los resultados a continuación son de la prueba 
en la piel. 
Los resultados de su prueba de sangre se proporcionarán en el Informe Final de Resultados que se envía 
por correo entre 12 y 16 semanas después del examen. Si el resultado de la prueba de sangre para la 
tuberculosis es positivo, le notificaremos inmediatamente.  
Negativo     
Basado en las lecturas de la prueba en la piel, el resultado de su prueba de tuberculosis fue negativo 
(_____mm).  Esto significa que usted probablemente no ha estado infectado(a) con tuberculosis.  
Si desea hacer alguna pr egunta, puede llam ar grat is a la doctora Kathry n Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las  8:30 de la mañana y  las 6 :00 de la tard e, hora del 
Este. 
Inglés:        1-800-452-6115, oprima “2”    
Español:     1-800-452-6115, oprima “3”    
   Chino:            1-866-887-7996, oprima “1” 
    Coreano:        1-866-887-7996, oprima “2” 





HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT POSITIVE 
Participant Name:  Sample Number: 
Date skin test placed:  
 
MM/DD/YYYY 
Date skin test read: 
 
MM/DD/YYYY 
Two tuberculosis (TB) tests were performed as part of the Nationa l Health and Nutrition E xamination 
Survey: a skin test and a blood test.  Results below are for the skin test.   
The results from  y our blood test will be provide d i n the Final Report of Findings sent by  mail 12–16 
weeks after the examination.  If the blood test for TB infection is positive, we will notify you right away. 
 
 Positive 
Based on the skin readings, your test result for TB infection was positive (_____mm).  This means that it 
is possible that you were i nfected with tuberculosis at so me time during your life.  Most pe ople infected 
with tuberculosis never develop active TB disease.   People who are infected but do not have active 
disease cannot spread TB to any one else.  If no one has told you before that you may have been infected 
with TB, we strongl y recommend you take this report to your doctor or to the local health department as 
soon as you can.  Your doctor or the health department may want to do another test to see if you need 
medicine to prevent active TB disea se.  The address and contact phone n umber for further evaluation at 
your local health department is provided separately. 
 
If you have any questions, y ou m ay call Dr. Kathr yn Porter on one of o ur toll-free num bers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
English: 1-800-452-6115, press “2” 
Spanish: 1-800-452-6115, press “3” 
Chinese: 1-866-887-7996, press “1” 
Korean: 1-866-887-7996, press “2” 
Vietnamese: 1-866-887-7996, press “3” 
The NHANES survey is a research study.  Because no risk factor information was available at the time of 
the reading, a result of 10 mm or more of induration was considered positive. 
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HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – ADULT POSITIVE 
Nombre del participante:  Número de la muestra:  
Fecha en la cual se tomó la prueba en la piel:  
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de  Salud y Nutrición, se hicieron dos pruebas de  
tuberculosis: una prueba en la piel y una prueba de sangre. Los resultados a continuación son de la prueba 
en la piel. 
Los resultados de su prueba de sangre se proporcionarán en el Informe Final de Resultados que se envía 
por correo entre 12 y 16 semanas después del examen. Si el resultado de la prueba de sangre para la 
tuberculosis es positivo, le notificaremos inmediatamente.  
 Positivo 
Basado en las lecturas de la prueba en la piel, el resultado de su prueba de tuberculosis fue positivo 
(_____mm). Esto significa que es posible que usted estuvo infectado(a) con tuberculosis en algún 
momento de su vida. La mayoría de las personas infectadas con tuberculosis nunca presentan la 
enfermedad activa de tuberculosis. Las personas que están infectadas, pero no tienen la enfermedad 
activa, no pueden contagiar a nadie con tuberculosis. Si nadie le ha dicho antes que usted puede estar 
infectado(a) con tuberculosis, le recomendamos enfáticamente que le lleve este informe a su médico o al 
Departamento de Salud local tan pronto como pueda. Es posible que su médico o el Departamento de 
Salud le quieran hacer otra prueba para ver si usted necesita medicinas para prevenir la enfermedad activa 
de tuberculosis. La dirección y número de teléfono para evaluación adicional en su Departamento de 
Salud local se proporcionan por separado. 
Si desea hacer alguna pr egunta, puede llam ar grat is a la doctora Kathry n Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las  8:30 de la mañana y  las 6 :00 de la tard e, hora del 
Este. 
Inglés:        1-800-452-6115, oprima “2”       
Español:     1-800-452-6115, oprima “3”       
   Chino:            1-866-887-7996, oprima “1” 
   Coreano:        1-866-887-7996, oprima “2” 
   Vietnamita:    1-866-887-7996, oprima “3” 
La encuesta NHANES es un estudio de investigación. Dado que no había información disponible sobre el 
factor de riesgo al m omento de determinar el resultado, un resultado de 10 mm o m ás de endurecimiento 
se consideró positivo. 
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HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – CHILD NEGATIVE 
Participant Name:  Sample Number:  
Date skin test placed:  
MM/DD/YYYY 
Date skin test read: 
MM/DD/YYYY 
Two tuberculosis (TB) tests were performed as part of the Nationa l Health and Nutrition E xamination 
Survey: a skin test and a blood test.  Results below are for the skin test.   
The results from  y our child’s blood test will be prov ided in t he Final Report of Findi ngs sent by  mail 
12–16 weeks after the examination.  If your child’s blood test for TB infection is positive, we will notify  
you right away. 
Negative
Based on the skin test readings, your child's result for TB infection was negative (_____mm).  This means 
your child probably has not been infected with TB. 
If y ou have any questions, y ou m ay call Dr. Kathr yn Porter on one of o ur toll-free num bers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
English: 1-800-452-6115, press “2” 
Spanish: 1-800-452-6115, press “3” 
Chinese: 1-866-887-7996, press “1” 
Korean: 1-866-887-7996, press “2” 




HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – CHILD NEGATIVE 
Nombre del participante:  Número de la muestra: 
Fecha en la cual se tomó la prueba en la piel:  
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de Salud y Nutrición, se hicieron dos pruebas de 
tuberculosis: una prueba en la piel y una prueba de sangre. A continuación están los resultados de la 
prueba en la piel.   
Los resultados de la prueba de sangre de su niño(a) se proporcionarán en el Informe Final de Resultados 
que se envía por correo entre 12 y16 semanas después del examen. Si el resultado de la prueba de sangre 
de tuberculosis de su niño(a) es positivo, le notificaremos inmediatamente. 
 Negativo 
Basado en la s lecturas de la prueba en la piel, el resu ltado de la pr ueba de tuberculosis de su niño(a) fue 
negativo ( _____mm). Esto significa que su niño(a) probable mente no h a estado infectado con 
tuberculosis. 
Si desea hacer alguna pregunta, puede llamar gratis a la doctora Kathryn Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las 8:30 de la mañana y las 6:00 de la tarde, hora 
del Este.  
Inglés:        1-800-452-6115, oprima “2”                  Chino:            1-866-887-7996, oprima “1” 
Español:     1-800-452-6115, oprima “3”                  Coreano:        1-866-887-7996, oprima “2” 





HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS - CHILD POSITIVE 
Participant Name: Sample Number: 
Date skin test placed:  
MM/DD/YYYY 
Date skin test read:  
MM/DD/YYYY 
Two tuberculosis (TB) tests were performed as part of the Nationa l Health and Nutrition E xamination 
Survey: a skin test and a blood test. Results below are for the skin test.  
The results from  y our blood test will be provide d i n the Final Report of Findings sent by  mail 12–16 
weeks after the examination. If the blood test for TB infection is positive, we will notify you right away. 
Positive 
Based on the skin readings, y our child' s test  fo r TB was positive (_____mm ).  This means that it i s 
possible your child was infected with tuberculosis at some time in his/her life.  Most people infected with  
tuberculosis never develop active TB disease.  Peo ple who are infected but do not have active disease  
cannot spread tuberculosi s to an yone else.  If no one has told you before that your child may have been 
infected with TB, we stro ngly recommend you take  th is report to your chil d's doctor or local health  
department as soon as y ou can.  Your doctor or the h ealth department may want to do another skin test 
and an exa mination to see if y our child needs medicine to prevent active TB d isease.  The address and 
contact phone number for further evaluation at your local health department is provided separately. 
If y ou have any questions, y ou m ay call Dr. Kathr yn Porter on one of o ur toll-free num bers below 
between 8:30 AM and 6:00 PM Eastern Time, Monday through Friday. 
English: 1-800-452-6115, press “2” 
Spanish: 1-800-452-6115, press “3” 
Chinese: 1-866-887-7996, press “1” 
Korean: 1-866-887-7996, press “2” 
Vietnamese: 1-866-887-7996, press “3” 
The NHANES survey is a research study.  Because no risk factor information was available at the time of 
the reading, a result of 10 mm or more of induration was considered positive. 
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 HOME VISIT TUBERCULOSIS SKIN TEST REPORT OF FINDINGS – CHILD POSITIVE 
Nombre del participante:  Número de la muestra:  
Fecha en la cual se tomó la prueba en la piel:  
MM/DD/YYYY 
Fecha en la cual se leyó la prueba en la piel: 
MM/DD/YYYY 
Como parte de la Encuesta Nacional de Examen de Salud y Nutrición, se hicieron dos pruebas de 
tuberculosis: una prueba en la piel y una prueba de sangre. A continuación están los resultados de la 
prueba en la piel.   
Los resultados de la prueba de sangre de su niño(a) se proporcionarán en el Informe Final de Resultados 
que se envía por correo entre 12 y16 semanas después del examen. Si el resultado de la prueba de sangre 
de tuberculosis de su niño(a) es positivo, le notificaremos inmediatamente. 
Positivo 
Basado en las lecturas de la prueba en la piel, el resultado de la prueba de tuberculosis de su niño(a) fue 
positivo (_____mm). Esto significa que es posible que su niño(a) estuvo infectado(a) con tuberculosis en 
algún momento de su vida. La mayoría de las personas infectadas con tuberculosis nunca presentan la 
enfermedad activa de tuberculosis. Las personas que están infectadas, pero no tienen la enfermedad 
activa, no pueden contagiar a nadie con tuberculosis. Le recomendamos enfáticamente que le lleve este 
informe al médico de su niño(a) o al Departamento de Salud local tan pronto como pueda. Es posible que 
el médico de su niño(a) o el Departamento de Salud quieran hacer un examen para ver si su niño(a) 
necesita medicinas para prevenir la enfermedad activa de tuberculosis. La dirección y número de teléfono 
para evaluación adicional en su Departamento de Salud local se proporcionan por separado. 
Si desea hacer alguna pregunta, puede llamar gratis a la doctora Kathryn Porter a uno de nuestros 
números a continuación, de lunes a viernes, entre las 8:30 de la mañana y las 6:00 de la tarde, hora 
del Este.  
Inglés:        1-800-452-6115, oprima “2”                  Chino:            1-866-887-7996, oprima “1” 
Español:     1-800-452-6115, oprima “3”                  Coreano:        1-866-887-7996, oprima “2” 
                                                                                   Vietnamita:    1-866-887-7996, oprima “3” 
La encuesta NHANES es un estudio de investigación. Dado que no había información disponible sobre el 
factor de riesgo al momento de determinar el resultado, un resultado de 10 mm o más de endurecimiento 
se consideró positivo. 
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